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Aim: The aim of this study is to explore and describe the perceived levels of HIV related stigma 
and disclosure patterns among women living with HIV and AIDS. 
Objectives: The objectives of the study are to explore and describe the perceived levels of 
stigma and disclosure patterns among women, the inter-relationship between demographic 
variables and perceived levels of stigma, the inter-relationship between demographic and 
disclosure patterns and the inter-relationship between perceived patterns of disclosure and 
perceived stigma levels. 
Method: A quantitative explorative, descriptive study design was used for the study. Purposive 
sampling was used by the researcher to select a sample of women who were attending a clinic 
within a selected hospital in KwaZulu-Natal. A self-reported questionnaire was administered to a 
sample of 90 women, all of which were completed and returned. 
The data obtained from the questionnaire was analysed using SPSS version from SPSS Survival 
Manual Fourth edition, 2011. Descriptive and non-parametric testing was used to show levels of 
perceived stigma, disclosure patterns and inter-relationships between demographic variables and 
perceived HIV related stigma and disclosure patterns.  
Results: The results showed that the majority of the participants had perceived low stigma levels 
and the majority disclose their status. Item one (1) where 12% have not disclosed their status to 
family. Item six (6), 43.3% feel that they do not have to keep their status a secret. Item eight (8), 
33.3% agreed that they never felt ashamed of HIV and item nine (9), 42.2% disagreed that 
people with HIV are treated as outcasts. 
There was a weak correlation between the age of the participants and stigma, and there was a 
positive weak relationship (r=0.086) between age and disclosure. There was a positive weak 
correlation between disclosure and stigma (r=0.18+p=0.1). 
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1. INTRODUCTION AND BACKGROUND OF THE STUDY 
1.1 Introduction 
South Africa has the greatest number of people living with HIV of any country in the world 
(Velloza et al. 2015). High levels of HIV stigma have been documented by many studies in 
South Africa, which could explain drop-offs in HIV care engagement (Dos Santos  et al. 2014).  
Stigma negatively impacts the uptake of HIV testing, with individuals who perceive HIV related 
stigma or observe enacted stigma far less likely to get tested for HIV (Nyblade et al. 2013). The 
evidence based interventions focused on HIV prevention, treatment, care and support have been 
implemented with some success, although the prevalence of HIV has remained high, while the 
researcher‘s review revealed considerable progress in the stigma-reduction field over the last 
decade (Stangl et al. 2013). South Africa continues to monitor the epidemic and is continually 
assessing, strengthening and reviewing the response to HIV (Shisana et al. 2014). HIV related 
stigma prevents the effective use of antiretroviral treatment, especially in women living with 
HIV, due to fear of partner abandonment or abuse following disclosure of their HIV status 
(Black et al. 2014). 
1.2 Background of the study 
1.2.1 HIV prevalence in South Africa 
South Africa has the biggest and most high-profile HIV epidemic in the world, with an estimated 
seven million people living with HIV in 2015. In the same year, there were 380,000 new 
infections while 180,000 South Africans died from AIDS-related illness. South Africa has the 
largest antiretroviral treatment (ART) programme globally, however HIV prevalence remains 
high (19.2%) among the general population. HIV prevalence is almost 40% in KwaZulu-Natal 
compared with 18% in the Northern Cape and the Western Cape representing 17% of the global 
burden of HIV infection (Zuma, Shisana et al. 2016; UNAIDS, 2013).The results of the analysis 
of HIV prevalence estimated by key demographic variables which suggests that the overall 
prevalence differed substantially by provinces,  and provincial variation was evident with the top 
four HIV prevalent provinces being KwaZulu-Natal, Mpumalanga, Free State, and North West, 
with the lowest being Western Cape (Shisana et al. 2014). It has been indicated that black 
African females between the ages of 30- 34 have a high HIV prevalence, while female teenagers 
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aged 15-19 are also high in HIV prevalence in South Africa (Okoror et al. 2014). In KwaZulu-
Natal the eThekwini district and Ekurhuleni in Gauteng have the highest HIV prevalence, with 
women who are of a childbearing age being at a greater risk of exposure to HIV, and therefore 
the need to access the programme that was introduced to the pregnant women in order to prevent 
transmission of HIV infection from mother to child during pregnancy, that programme was 
called the prevention of mother-to-child transmission (PMTCT) is essential (Shisana et al. 2014). 
In Zimbabwe the prevalence of HIV is high in adolescents from the age of 15-19, therefore their 
government has introduced shaping the health of adolescents in Zimbabwe (SHAZI), and in 
doing so they are trying to decrease the high burdens of HIV infection and the HIV stigma which 
leads to poor economic and lack of educational status in young women, however the poor 
educational status may also affect the proper understanding of the spread of the HIV infection 
and PMTCT (Tsai et al. 2013). 
 
Stigmatising attitudes and behaviors are shaped by social and cultural contexts, which reinforces 
the need to target settings where HIV related stigma is most harmful but also modifiable. 
Comparative studies conducted throughout Africa have shown that expressions of stigma such as 
blamingothering differ based on socio-economic resources, norms and the availability of 
supportive services (Velloza et al. 2015).  HIV related stigma continues to affect people living 
with HIV and affected by HIV disease and their healthcare providers, particularly in regions 
where HIV and AIDS is widespread, such as in Southern Africa. Pregnant women report 
difficulties in accessing the PMTCT programmes due to the negative attitudes of healthcare 
providers, families and spouses (Dos Santos et al. 2014).  The National Strategy Plan (NSP) for 
2012–2016 states as its primary goal, a reduction of new infections by at least 50%, this will be 
extremely difficult to attain given the prevailing transmission dynamics in the country (Naidoo, 
2014). 
HIV related stigma and discrimination remain major barriers to effective HIV prevention as well 
as to the provision of treatment, care and support in many countries across the globe, including 
South Africa (Zuma et al. 2016). An important aspect of such stigma is the phenomenon of 
‗othering‘ whereby some people do not believe they are at risk of HIV infection on account of 
their sex, race, creed, religion, sexual preferences or national origin (Black et al. 2014). Many 
countries in the East and the Southern African region, including South Africa were committed in 
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the National Strategy Plan to the reduction of new infection by 50% (Suofeiya et al. 2017). More 
than two-thirds (23.5 million) of all HIV infected people worldwide live in Sub-Saharan Africa 
(Psaros et al. 2015). In South Africa (KwaZulu-Natal), adult HIV prevalence has exceeded 20% 
for at least a decade (Tsai et al. 2013). Globally, it is estimated that there were 35.3 million 
people living with HIV and 2.3 million new infections in 2012. Although the burden of the 
epidemic varies considerably between countries and regions, it is estimated that 0.8% of adults 
aged 15–49 years worldwide are living with HIV. The HIV and AIDS epidemic remains a 
serious public health challenge, especially among women of childbearing age, who make up 46% 
of the global HIV burden (Shisana et al. 2014). Who, 2013 also highlights that women constitute 
52% of all HIV infections in low- and middle-income countries (Shisana et al. 2014) 
 
The prevention of mother-to-child transmission (PMTCT) is a complex challenge in heavily 
affected and resource-limited settings such as South Africa and Sub-Saharan Africa, however 
management of PMTCT requires a cascade of interventions that need to be addressed to 
effectively decrease the risk of HIV transmission to infants and the PMTCT cascade includes 
incremental components that can be shaped and influenced by the patient-provider relationship 
(Yeji et al. 2014). The impact of stigma manifests itself both at individual and community level 
and it has been a major obstacle to the effective implementation of and adherence to PMTCT and 
antiretroviral treatment (Ngarina et al. 2014). Postpartum attrition is of particular concern with 
up to 50% of women dropping out of care after delivery and among HIV positive adults in Sub-
Saharan Africa, the denial of infection, stigma, and lack of family or community support, 
transport limitations, and long queues at healthcare facilities are cited as barriers to retention 
(Clouse et al. 2014).  
 
1.2.2 Stigma and discrimination as barriers to achievement of global PMTCT and 
maternal health goals 
In the context of this study HIV stigma refers to any unacceptable label that is given by others to 
a person who is infected with HIV such as gossip, isolation and labeling. Stigmatising and 
discrimination against people living with HIV and AIDS has been one of the hallmarks of the 
global HIV pandemic (Famoroti et al. 2013). HIV related stigma acts as a negative driver in 
compliance with ART as emphasized in the study conducted in Mpumalanga province in South 
Africa whereby participants reported their fear to take medication in front of their husbands and 
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spouses (Dos Santos et al. 2014). Although an ART and PMTCT service has reshaped the AIDS 
response, the HIV treatment revolution has yet to reach many around the world. Only modest 
gains in ART and PMTCT coverage have been reported in Eastern Europe and Central Asia as 
well as the Middle East and North Africa, and ART eligible individuals in West and Central 
Africa are notably fewer (Black et al. 2014).  PMTCT services will not be effective if people are 
not accessing them, and the lack of uptake and access to HIV testing and subsequently treatment 
services also diminishes the health benefits of treatment at both the individual and population 
levels (King et al. 2013). 
Stigma continues to prevent quality healthcare for the mother and the unborn baby, therefore it 
may increase the susceptibility of advancing HIV disease in pregnancy (Turan and Nyblade 
2013). Stigma also has other effects on health which include poor mental health, maternal 
mortality and morbidity, infant mortality and morbidity, adverse health consequences of violence 
and transmission of infections (Turan and Nyblade 2013). Research has found that the 
ramifications of HIV related stigma on health seeking behaviours may result in individuals 
fearing to get tested, and people living with HIV responses include delaying or not adhering to 
treatment and potentially not adopting preventative behaviours (Churcher,  2013). Women face 
challenges in disclosing their HIV status which leads to poor health and prevention of disease in 
Southern Mexico (Ojikutu et al. 2016), as outlined in the following section. 
1.2.3 Disclosure and perceived HIV stigma 
Perceptions of HIV-related stigma may play a major role in decisions about HIV disclosure 
(Teklehaimanot et al. 2016). High levels of HIV stigma act as a barrier in prevention of HIV 
programmes and it also limits the uptake of safer sexual behaviours and HIV testing and 
treatment (Dos Santos, et al. 2014). However, HIV related stigma is also related to the 
endorsement of reasons against HIV disclosure to certain relationship partners. It is said that the 
greater the belief that the public stigmatizes someone with HIV, the greater the endorsement of 
self-blame, fear of rejection, communication difficulties and protection of others. Hence the 
reasons for not disclosing HIV status leads to poor support for the person concerned (Akullian et 
al. 2014). 
 
Further to this, it is also noted that perceived levels of HIV stigma affects HIV disclosure among 
people living with HIV (Akullian et al. 2014). Hence perceived HIV stigma is associated with 
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greater sensitivity to the potential negative consequences of disclosing to a friend, parent and 
intimate partner, however negative consequences affect HIV decision making hence 
nondisclosure affects or decreases access to support from friends, parents and intimate partners 
(Velloza et al. 2015). Certain demographic and reproductive factors also affect HIV stigma 
levels, as outlined in the following section. 
 
1.2.4 Demographic factors and reproductive factors that affects HIV stigma levels 
Socio-demographic factors influence HIV stigmatization and discrimination among women 
living with HIV (Darlington and Hutson 2016). A study conducted in Nigeria indicates that age 
and educational attainment have negative influence on HIV stigmatization and discrimination, 
hence the women reported that once they disclose their HIV status, they are gossiped about, 
verbally harassed  and neglected by Nigerian society (Zuma et al. 2016). A high HIV stigma 
level was consistently and significantly associated with low social support, poor mental health 
and age, however the community environment may also influence in shaping HIV related stigma 
among women such as economic and behavioral aspects of the community environment (Pantelic 
et al. 2015).  Another factor that was mentioned in the literature is the religious factor, which 
plays a role in people‘s attitudes about HIV and people living with HIV (Valencia-Garcia et al. 
2016). A study that was conducted in Pretoria, South Africa states that a high educational level 
such as tertiary, and urban or rural residence status was significantly associated with willingness 
to disclose (Przybyla et al. 2013). However the study in the United States of America indicates 
that married couples, highly educated, with better housing and those who are less financial 
dependent disclose more easily and levels of stigma are lower (Ebuy et al. 2015). Education and 
wealth are positively related to certain risk factors such as premarital sex and associated with 
high HIV prevalence (Teklehaimanot et al. 2016). 
 
1.3 Problem statement 
HIV related stigma remains the major problem worldwide, which affects HIV status disclosure 
especially in women (Black et al. 2014). HIV programmes and services were implemented long 
time ago to support people living with HIV, and it shows that people default to take medication 
due to the fear of being stigmatized. Women are the most vulnerable group especially those of 
childbearing age from 25-35 years (Darlington and Hutson, 2016). The researchers indicate that 
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many women get pregnant after initiating antiretroviral drugs (Black et al. 2014, Shisana et al. 
2014). Prevention of mother- to-child transmission services were introduced to initiate all HIV 
pregnant women to lifelong antiretroviral drugs (Clouse et al. 2014). In the context of the recent 
PMTCT guidelines change where all women commence ART during pregnancy and within 
Option B+, Option B+ where women choose exclusive breastfeeding option, lifelong ART for all 
pregnant women and breastfeeding women with HIV were strategies that has been introduced by 
World Health Organization guidelines for PMTCT to prevent  the majority of women and service 
providers reinforced a concept raised by researchers of the ―triple burden‖ of accepting that they 
are pregnant, newly diagnosed as HIV-positive and eligible for lifelong treatment (Govender et 
al. 2014). Previous researchers have documented high levels of HIV related stigma in South 
Africa that could explain drop-offs in HIV care engagement (Dos Santos et al. 2014). In 
KwaZulu-Natal, it is indicated that people who are HIV positive face challenges when they need 
to take their treatment, due to high levels of stigma among community, family, partners and 
healthcare workers (Yeji et al. 2014). 
 Among people living with HIV, HIV stigma is also a significant barrier to linkage to HIV care 
and adherence to treatment regimens (Velloza et al. 2015). Many women are dropping out of 
treatment after delivery, as they fear being stigmatized within the community and family when 
they continue collecting their ARVs in the healthcare centre (Black et al. 2014). The researcher 
therefore deems it imperative to conduct a study to explore and describe the perceived levels of 
HIV related stigma and disclosure patterns among women living with HIV in a selected regional 
hospital in the eThekwini District, KwaZulu-Natal. 
1.4 Aim of the study 
The aim of this study is to explore and describe perceived levels of HIV related stigma and 
disclosure patterns among women living with HIV and AIDS in a selected regional hospital in 
the eThekwini District. 
 
1.5 Objectives of the study 
1.5.1 Objectives of the study were to explore and describe the 
(a) Perceived levels of HIV related stigma among women living with HIV and AIDS. 
(b)  Patterns of HIV disclosure among women living with HIV and AIDS. 
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(c) Inter-relationship between demographic variables and perceived levels of stigma 
among women living with HIV and AIDS. 
(d)  Inter-relationship between demographics and disclosure patterns among women 
living with HIV and AIDS. 
(e)  Inter-relationship between patterns of disclosure and perceived stigma levels 
among women living with HIV and AIDS. 
 
1.5.2 Research questions 
(a) What are the perceived levels of HIV related stigma among women living with HIV 
and AIDS? 
(b) What are the patterns of disclosure among women living with HIV and AIDS? 
(c) What is the inter-relationship between demographic variables and perceived levels of 
stigma among women living with HIV and AIDS? 
(d) What is the inter-relationship between demographic variables and patterns of 
disclosure among women living with HIV and AIDS? 
(e) What is the inter-relationship between patterns of disclosure and perceived stigma 
among women living with HIV and AIDS? 
1.5.3 Significance of the study 
(a) Nursing practice 
The information from this study may assist nursing practice to improve their standards in 
confidentiality and positive attitudes towards HIV positive women. Findings may also assist 
the promotion of universal care in the healthcare centres by combining services, such as 
ARV‘s treatment, diabetes treatment, hypertensive drugs etc. in one room, as a study in Cape 
Town where women stated that they are treated in a separate room and even their files are not 
the same as others due to their HIV status (Turan and Nyblade 2013). 
(b) Nursing research 
The research findings will form a baseline for further research to be utilized by the nurse 
researchers in order to implement this information and also to identify gaps. The implementation 
of a strategy that might be effective in combating stigma among women is needed, and steps 
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should be taken to put this in place. The strategy planning to reduce HIV stigma in women was 
approved at multiple levels and by all relevant parties, including the South African National 
AIDS Council (SANAC), which is assisting in developing indicators of stigma associated with 
HIV and AIDS (French et al. 2015). 
 
(c) Nursing policies 
The information from this study may assist policy makers to develop policies related to HIV 
mitigation strategies tailored for women living with HIV. As the literature states, policy makers 
need to plan programmes that might combat HIV stigma among women as it is a major barrier 
for accessing healthcare services (Kamen et al. 2015). 
(d) Community 
The information from this study may encourage community members to support people living 
with HIV. The researchers introduced HIV stigma reduction interventions focusing on the 
community as a whole, in the form of outreach activities, and their aim is associated with caring 
for people living with HIV. There are home visit care teams who encourage the community to 
take care of affected and infected people and reduce the stigmatising of people who are HIV 
positive (French et al. 2014). 
1.5.4. Definitions of terms used in this study 
 (a) Prevention of Mother-to-Child Transmission (PMTCT) 
PMTCT is the strategic plan that was introduced to reduce HIV transmission from a mother to 
her child (Simelela et al. 2015). In the context of this study PMTCT refers to the prevention of 
the unborn babies contracting HIV by the pregnant women taking antiretroviral treatment during 
pregnancy till delivery if the mother is HIV positive. 
(b) HIV positive 
It is the period between a person being infected with HIV and HIV antibodies being detectable 
by a serological assay human (World Health Organization, 2016). In this study HIV positive 





(c) HIV related disclosure 
It is considered as a way to open up the HIV epidemics and hence is a crucial step toward ending 
stigma and discrimination against people living with HIV and AIDS (Ullah, 2011). In this study 
HIV related disclosure refers to someone who discloses her HIV status and response from those 
people she disclosed to. 
1.6 Theoretical framework underpinning study 
The theoretical framework is the main idea that the researcher holds about the phenomenon of 
interest which may or may not be written (Frank et al. 1998). 
Theoretical framework is the primary conception or model of what is out there that the 
researcher plans to study and what is going on with such conceptions (Frank et al. 1998). A 
conceptual framework is a written product that explains, either in narrative or graphical form, the 
phenomenon to be studied, the key factors, the concepts or variables as well as their relationships 
(Miles et al. 1994).  
The researchers propose a framework of social inequality as a strategy to understanding stigma 
and also urge the recognition of other contextual factors, such as culture and its impact on power 
relationships, in order to understand stigmatization as a process of social structures (Holzemer et 
al. 2007). The contextual framework was proposed in which stigma occurs such as the symbolic 
context, the economic, political and local community context, and organizational context of 
institutions working to address HIV and AIDS stigma (Holzemer et al. 2007). Many researchers 
propose the definitions of stigma, and have investigated its impact and correlate and propose 
frameworks for thinking about stigma. They use data based approaches to integrate theories on 
the context and process of stigma which is based on the data and personal experiences that the 
researchers have working with HIV clients, they conceptualize the stigma process to include 
triggers of stigma, stigmatizing behaviour, types of stigma and the outcomes of stigma. They 
combine the stigma process with the context of stigma and create a conceptual model of HIV 




1.6.1. HIV Stigma Model 
In this study, the HIV Stigma model developed by Holzemer and colleagues underpinned the 
study (Holzemer et al. 2007). According to this model, the stigma process is conceived to occur 
within three contextual factors namely environment, the healthcare system and the agent. 
Environmental factors include cultural, economic, political, legal and policy environment 
(Holzemer et al 2007). Politics focuses on the sense of power relationships, whereby people 
living with HIV and AIDS are stigmatized in the cultural aspects, economic, legal and policy 
environments. People who stigmatize others may have a secondary gain, which leads them to 
have the power to stigmatize others. The process of stigmatizing might also increase their 
perceived power. It also noted that the legal and policy environment are secondary aspects which 
influence the response to an illness. There is a limited understanding of the elements which 
increase and decrease stigma to people living with HIV and AIDS. In public health measures, 
other countries have laws and policies that discriminate against people who are living with HIV 
and AIDS (Holzemer et al. 2007), as outlined in figure 1.1.The stigma process discussed more 




Figure: 1.1.Model of the dynamics of HIV and AIDS stigma (Holzemer et al. 2007). 
 
The stigma process is outlined in more detail in the following sections.  
1.6.2. The stigma process 
According to the model, the stigma process takes place in context and is proposed to include four 
elements, such as stigma triggers, stigmatizing behaviour, types of stigma and stigma outcome. 
1.6.3. Stigma triggers 
The stigma process can be triggered by HIV diagnosis or disclosure of HIV status. Triggers can 
be defined as any action that allows people to label themselves or others as HIV positive. 
Received stigma can be triggered by disclosure, and associated stigma can be triggered by 
continued association with a person who is either suspected of being HIV positive or having 
AIDS. Many people who are HIV positive indicated that the suspicion of being HIV positive is 




1.6.4. Stigmatizing behaviour 
Triggers lead to stigmatizing behaviour that may harm, isolate, exclude or identify the person in 
a negative way. However, this kind of stigma is not limited, whereby a person may be forced to 
move home due to his or her HIV status. 
 
1.6.5. Types of stigma 
Three types of stigma have been identified from the data such as received, internal and 
associated. This refers to a state when a person living with HIV is neglected, rejected, avoided by 
others, and others gossip about her or him due to HIV status, it is referred to as received stigma, 
whereas internal stigma includes perception of self, social withdrawal, self-exclusion and fear of 
disclosure. Associated stigma explained by Holzemer and colleagues (2007) involves examples of 
stigma that result from a person's association with someone living with, working with or otherwise 
associated with people living with HIV/AIDS. (Holzemer et al. 2007).  
 
Explained by Holzemer and colleagues (2007), the consequences and outcomes of stigma can be 
categorised within general health, violence, poor quality of life and reduced access to care, and 
that poor health as an outcome of stigma but not restricted to physical health, but also includes 
mental health, since social exclusion, rejection, high stress due to stigma and economic pressures 
may lead to stress-related mental illness. In this study, the researcher did not focus on the 
outcomes of stigma, but rather on the perceived stigma experienced by the women living with 
HIV.  
 
1.7. Application of the model of the dynamics of HIV stigma in the study 
Based on the model of the dynamics of HIV stigma, as applied to this study, figure 1.2 shows the 
stigma process which takes place with contexts and proposes to include three elements such as 
stigma triggers in relation to this study. These refer to environmental aspects, such as 
demographics like rural places, low socio-economic status and low education which are factors 
that influence stigmatizing behaviour. Perceived stigma follows where a person blames herself, 
is ashamed and fears being rejected by the agents who are the community and family and 
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highlights the types of stigma. Perceived stigma may affect healthcare and the person may avoid 
attending services like PMTCT, family planning, and immunization. 
 
 
Figure: 1.2.  HIV stigma model adapted for study 
1.8. Summary of this chapter 
HIV stigma on women acts as a major barrier in improving adherence to treatment. Not enough 
is known about what happens to the care of HIV-infected mother after the completion of the 
Triggers 
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PMTCT cascade. Keeping women healthy is a worthy and important goal on its own, however, 
keeping women engaged in HIV care will likely have far reaching benefits globally to reduce 
HIV transmission (Psaros et al. 2015). Stigma impacts beyond the individual infected with HIV, 
to affect all those associated with the disease. It can also impact on society more generally, by 
extending the epidemic and undermining whatever behaviour and treatment interventions are 
already in place. Thus interventions need to be introduced to reduce stigma and encourage 














2. LITERATURE REVIEW 
2.1.Introduction 
This chapter presents the discussion of the literature that was reviewed in relation to the aims of 
this study. A review of literature is a process that entails identifying and analysing potentially 
relevant information resources in relation to one‘s research study (Terre Blanche et al., 2006). It 
is necessary to begin this chapter with an overview of the local and global extent of HIV and 
AIDS, the context of women and HIV, and women receiving treatment such as HIV/AIDS 
Antiretroviral Treatment (HAART) and PMTCT. This will be followed by success drivers in 
HIV interventions and the social stigma regarding HIV and AIDS among women. AIDS stigma 
continues to affect people living with and affected by the HIV disease and their healthcare 
providers, particularly in regions where HIV and AIDS is widespread, such as southern Africa. 
Stigma has emerged as a major barrier to HIV and AIDS care, as well as to primary and 
secondary prevention (Holzemer et al. 2007). As mentioned above, literature was searched via 
the internet and previous research studies. 
2.1.1. Overview of HIV locally 
South Africa is at the epicentre of the HIV epidemic and other sexually transmitted infections 
(STI) continue to be endemic. KwaZulu-Natal, the most densely populated province in South 
Africa, has been markedly affected by both the HIV and STI epidemic with a disproportionate 
burden of STI and HIV among women (Naidoo et al. 2014). In South Africa during the past two 
decades, gender-based violence and gender inequality in relationships have been associated with 
increased risk of HIV in women, however cessation of violence against women and girls is one 
of the priority areas in the UNAIDS outcome frame for 2009 to 2011, and national HIV strategic 
plans, such as acknowledge the need to address gender issues (Putrajaya, 2015).  Although 
preventive measures have been introduced, such as medical male circumcision and condom used 
and antiretroviral drugs, but women are faced with challenges of new infections. Women are 
vulnerable due to low socio-economic status (King, 2013). The cross-sectional studies in rural 
South Africa indicate that women who experience intimate partner violence and have high 
gender inequality in relationships have increased incidence of HIV infections (Naidoo et al, 
2014). In Sub-Saharan Africa, young girls aged 18-24 years are eight times more likely than men 
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of the same age group to be HIV positive (Yeji et al. 2014). This indicates that HIV affects the 
majority of women in their reproductive ages and their economically productive years. In sub-
Saharan Africa, women remain disproportionately affected by the HIV epidemic, accounting for 
58% of all people living with HIV in the region (Colombini et al. 2014). 
 
2.1.2. Overview of HIV globally 
In 2015, 36.7 million people were living with HIV worldwide, with new HIV infections in the 
same year estimated at 2.1 million, and AIDS-related deaths at 1.1 million. Due to women 
accounting for a huge proportion of people infected and affected by HIV and AIDS globally, the 
United Nations (UN) agencies and other policy makers have often referred to the phenomenon of 
feminisation of HIV and AIDS (WHO, 2016). The global HIV epidemic commands our attention 
study conducted in Asia focuses on women due to the growing feminisation of the HIV epidemic 
and elevated HIV stigma that women face, particularly in the Muslim world. 87% of Muslim 
women state that they are reluctant to be tested for fear of gender-based violence or loss of 
financial support (Turan et al, 2013). The general decline in new HIV infections are noted in sub-
Saharan Africa (SSA), however in 2013 the region was responsible for 72% of all HIV infections 
globally (Mafigiri et al. 2017). Worldwide surveillance data indicate that HIV infections have 
increased at alarming rates in developing countries (WHO, 2014). African countries such as 
Malawi and Zambia have had an impact on the morbidity and mortality due to low income, poor 
nutrition, and insufficient access to medical care (Kamen et al. 2015). The study conducted in 
South Western Uganda reported higher prevalence of HIV especially among young females and 
in landing site communities than in the peripheral communities, then the urgent for youth-
friendly services is needed in these communities (Mafigiri et al. 2017). 
2.2. Context of women and HIV in South Africa 
The AIDS epidemic is one of the most destructive epidemics that the world has witnessed 
(Evangeli et al. 2014). South Africa has the biggest and most high profile HIV epidemic in the 
world, with an estimated 7.1 million people living with HIV in 2016, however one third of all 
new infections in the region in 2016 were in one country, South Africa (Zuma et al. 2016). The 
risk of MTCT ranges from 15% to 40%, however in high income countries the MTCT rate may 
be as low as 1% to 2%. There are discrepancy in the rate of infection in high income countries 
compared to limited-resource countries, it is of because the campaign that they introduced such 
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as a greater awareness among women, accessible information, and higher socio-economic status 
and educational levels of women and the community (Ebuy et al. 2014). Researchers have 
widely documented the pervasiveness of HIV stigma and discrimination at a community level, 
and its impact on accessing HIV prevention and treatment, and care and support services. It can 
also create barriers to the use of condoms and uptake of HIV testing and the prevention of 
mother-to-child transmission programmes (PMTCT) as well as other services (such as legal, 
employment, psychosocial care) (Ngarina et al. 2014). A study in rural Kenya suggests that HIV-
related stigma is associated with a low rate of delivery by skilled attendants (Colombini et al. 
2014). HIV stigma in Africa has been documented to be an impediment to disclosure of HIV 
status, with studies indicating that between 3, 5% to 14%, and 6% of women reportedly 
experiencing a violent reaction from a partner after HIV disclosure (Black et al, 2014). A number 
of international and local South African studies indicated the complex links between poverty, 
gender power relations, intimate partner violence, drug use and HIV among women, and findings 
in a study conducting in Cape Town in a black township, revealed that AIDS was only one of 
many major social stressor threatening people living in everyday poverty (Dos-Santos et al. 
2014). 
2.3. Women and HIV care and treatment 
A study that was conducted in Cape Town, South Africa states that there were missed 
opportunities to initiate HAART among pregnant women with advanced HIV disease within the 
public sector antenatal care services (Okoror et al. 2013). Data from other researchers indicates 
that only 51% of HAART eligible women initiated treatment before delivery, while another 27% 
received a short course PMTCT regime, and more than one-fifth of women received no 
intervention (Dos Santos et al. 2014). The World Health Organization revised its ART treatment 
guidelines to recommend the initiation of HAART in all adults including pregnant women with 
CD4 cell counts of 350 cells; however the majority of women prefer Option B+ for PMTCT 
during breastfeeding period because of the stigma and discrimination associated with HIV and 
ART in the society (Ngarina et al. 2014). It shows that women are facing challenges in starting 
HAART due to fear of treatment side effects and disclosure to family members and spouses. 
Approximately one-third of patients receiving ART in a public sector programme in rural 
KwaZulu-Natal are depressed, while this depression prevalence is very high, it is comparable to 
the levels found among ART patients in other settings in Africa (Yeji et al. 2014). Women 
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reported fears even if they do enrol in PMTCT programs or HIV care, due to of unwanted 
disclosure and stigma which may make it difficult for them to adhere to ART (Turan et al. 2013). 
In KwaZulu-Natal, South Africa, women who were pregnant, hide their PMTCT medications 
from boyfriends, family members, and employers; however in Kenya both rural and urban 
women reported that they also hide their HIV positive status from their family and neighbours 
due to stigma and discrimination (Turan et al. 2013). 
 
2.4. Success drivers in HIV interventions 
The South African Prevention of Mother-to-Child-Transmission (PMTCT) guidelines were 
amended in 2010 aligning them with WHO recommendations and the programme reported to 
have 98.8% coverage nationally for antenatal HIV testing, 78.3% CD4 cell count testing, 91.8% 
antiretroviral prophylaxis to mother and or baby, and 89% in feeding advice (Turan et al. 2013). 
The high coverage and improved efficacy of the interventions have resulted in a substantial 
reduction in new paediatric HIV infections at six weeks of age from 5.8% in 2009 to 3.5% in 
2010 and 2.7% in 2011, however this still translates into thousands of infants being infected 
annually.  South Africa updated the PMTCT guidelines again in March 2013, offering 
combination ART to all HIV-positive pregnant women irrespective of the CD4 cell count. Data 
indicates that a personal circumstance affects participation in PMTCT and adherence to therapy 
(Famoroti et al. 2013). Although great improvements have been made in reducing mother-to-
child HIV transmission in South Africa, HIV prevalence remains high (19.2%) among the 
general population. HIV prevalence is almost 40% in KwaZulu-Natal compared with 18% in the 
Northern Cape and the Western Cape (Zuma, 2016) hence a combination of individual, 
biomedical, and health system factors contribute to PMTCT failures (Ngarina et al. 2014). The 
PMTCT guidelines of 2015 introduced a new policy of doing Polymerase Chain Reaction (PCR) 
for all babies at birth, and no longer waiting for 6 weeks, and HIV-positive mothers repeated 
CD4 cell counts after deliver immediately (Psaros et al. 2015). 
 
Repeat testing at these times has since been incorporated into the updated PMTCT guidelines, 
programme in South Africa, which is a comprehensive community-level intervention that 
combines gender equity, anti-violence, and an HIV and AIDS education curriculum with a 
microcredit programme. International Men and Gender Equality Survey (IMAGE) is generally 
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seen as a successful intervention due to its efficacy in reducing gender based violence and its 
possible impact on HIV in the future, similarly, in Zimbabwe they introduced Shaping the Health 
of Adolescents in Zimbabwe (SHAZI) which is based on a microcredit and life-skills training 
and mentorship programme on gender and power and women‘s empowerment theories, which 
attempts to address gender inequality, poverty and HIV risk among orphaned girls (WHO, 2016). 
They assert that while Treatment as Prevention (TasP) shows great promise as a cost-effective 
intervention to reduce new HIV infections and reduce the global burden of HIV related disease, 
the implementation of these programmes face many challenges, because of the large number of 
people in need of treatment (Govender et al. 2014). The researchers stress that TasP to achieve 
optimal prevention effects, it will be particularly important to consider the precise context of the 
epidemic during TasP roll-out, focusing on particular key populations, for example, in more 
concentrated epidemic settings (Govender et al. 2014). The government also introduced 
Voluntary Medical Male Circumcision (VMMC) as a strategy plan to reduce spread of HIV to 
young male. Fear and stigma of HIV testing are regarded as barriers and they also describe 
perceptions of pain associated with the procedure and adverse events and the need to abstain 
from sex, the authors note that targeting adolescents for VMMC can be successful together with 
messages promoting the benefits of VMMC (Govender et al., 2014).  
 
2.5. Social trends 
 
HIV infected pregnant women report that HIV related stigma may be a barrier to the uptake of 
care, and contributes to the gap between the availability of Prevention of Mother-to-Child 
Transmission (PMTCT) services and the use of those services (Akullian et al. 2014). A study 
conducted in Kenya shows lower uptake of ART among women who are pregnant, as they 
reported that they feel ashamed of their HIV status, and the recent global scale-up of PMTCT 
services. It is estimated that roughly half of the HIV-infected pregnant women in low and 
middle-income countries receive ART for PMTCT, with wide country-level disparities in 
PMTCT coverage ranging from 5% to 10% in Sudan and Chad, to 80% to 90% in South Africa, 
Botswana, Swaziland, and Namibia (Akullian et al. 2014). In a study  conducted in Kenya, fear 
of stigmatization among pregnant women was thought to account for lower rates of uptake of 
PMTCT services during childbirth compared to rates of uptake of antenatal care (ANC) services, 
which are often accessed before a mother's HIV status is known and for which participation does 




The study conducted in Malawi indicated that HIV stigma is associated with greater levels of 
distress in Malawian women, and also highlights the need for more research and programme to 
reduce HIV stigma (Kamen et al. 2015). Kenya and American surveys indicate that 
communities‘ interventions should make a difference in stigma reduction such as influencing 
leaders, church leaders and healthcare services (Akullian et al. 2014). The stigma of HIV and 
AIDS is one of a social process that has been broadly assumed to adversely affect multiple facets 
of engagement in HIV-related care as well as other factors that may undermine antiretroviral 
drugs(ART) adherence, including HIV serostatus disclosure, social support and mental wellbeing 
(Katz et al. 2013).  
 
The issue of stigma is very important in the battle against HIV and AIDS in Africa since it may 
affect patient attendance at healthcare centres for obtaining antiretroviral (ART) medications and 
getting regular check-ups. Stigmatization creates an unnecessary culture of secrecy and silence 
based on ignorance and fear of victimization(Famoroti et al. 2013). There has been much 
progress made in the prevention of mother-to-child transmission (PMTCT) services, hence the 
serious challenges to these global goals given the low rates of utilization of these services in 
many settings, literature reviewed from low-income settings indicates that HIV related stigma 
affects utilization of the series of steps that women must complete for successful PMTCT. 
Stigma negatively impacts on services uptake and adherence at each step of this PMTCT cascade 
(Turan and Nyblade, 2013). 
 
Many researchers and activists argue that HIV and AIDS related stigma is a persistent force 
reducing the effectiveness of preventive measures. Stigma and discrimination are forms of 
barriers in HIV testing and adherence to treatment (Neuman et al. 2013). HIV related stigma is 
the most common thing worldwide, although women are the more predominant people who are 
facing challenges due to rejection by their partners, family members and community. Many 
researchers indicate that stigma is the major cause of the spread of HIV infection in the world 
(Marsicano et al. 2014). HIV and AIDS related stigma has been recognized as the third phase of 
the AIDS pandemic and a facilitator for the transmission of the HIV virus, leading to the lack of 
testing for HIV and non-adherence to ARV medications (Nyamathi et al. 2013a). 
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2.6. Women and stigma 
A study conducted in Malawi as mentioned in earlier on, indicates that Malawian women faced 
with greater problem of stigma and discrimination in society, which involves societal rejection 
and development of a social identity (Kamen et al. 2015). Studies stated that women account for 
half of the people living with HIV worldwide, and they experience more stigma than men, 
therefore they are often perceived as vectors for disease transmission who spread HIV to men via 
sex work and unborn foetuses (Valencia-Garcia et al. 2016). Several studies conducted in 
African countries, Ethiopia, Mozambique and Uganda also mentioned gender inequality to 
women and men, hence they view stigma and disclosure patterns as poor health in women due to 
social rejection (Geary et al. 2014). A study conducted in one of the hospitals in KwaZulu-Natal, 
South Africa reports that patients are required to undergo HIV tests before surgery, reports that 
86% of healthcare workers agree with this action of pre-operative HIV testing (Famoroti et al. 
2013). Similarly, another study from Nigeria reports that 56% of healthcare workers indicated 
that they were not prepared to operate on a person without them being HIV tested. A Polish 
study amongst doctors and nurses shows that 56% of doctors and 65% of nurses support HIV 
testing of all inpatient admissions, while pre-operative testing of all surgical cases is supported 
by over 90% of doctors and nurses. These findings and negative attitudes by doctors and nurses 
could be traced back to the prejudicial attitudes that some healthcare workers have towards 
people who are HIV positive, associated with the belief that those infected with HIV and AIDS 
are promiscuous or prostitutes and deserve whatever they got, however it could also be related to 
fear of infection (Famoroti et al. 2013). 
The stigma motivated some women to avoid taking their medications due to fear of their spouse, 
as stated by HIV-positive women in western Nepal, and Indian women also mentions high levels 
of stigma, they are not allowed to share food, utensils and even to care for children (Katz et al. 
2013). Stigma relates to the beliefs and attitudes of people and it comes in diverse forms which 
may include refusal to provide medical care for HIV-positive women (Churcher, 2013). 
Reviewers of studies report that 15% of women who are HIV-positive experience violence after 
disclosure in Africa and Asia, and 4% in the United States of America (Neuman et al. 2013). 
Women who are living with HIV and AIDS face the pervasive all-encompassing stigma which 
reflects the myriad of challenges such as failure to cope with their illness. A study conducted in 
Tanzania states that stigma still remains strong, and reveal that stigma is very high in mothers 
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who are pregnant and the impact of stigma manifests itself and has been a major obstacle to the 
effective large implementation of and adherence to PMTCT and ART (Ngarina et al. 2014). 
2.7.Measures of stigma among people living with HIV and AIDS (PLWHA) 
Measuring HIV and AIDS stigma, whenever applicable, encourages the use of valid and reliable 
stigma measures by research projects and programme implementers. Stigma is considered one of 
the greatest challenges to addressing the HIV epidemic, data that accurately describes and 
quantifies stigma is often not available to programme implementers and policy makers. 
Consistent and widespread surveillance of stigma, utilising valid measures would also enable 
programme implementers to identify and assist specific at-risk and HIV-positive sub-groups who 
may be experiencing heightened perceived or enacted stigma when accessing prevention and 
treatment programmes (Nyamathi et al. 2013). Several instruments designed to measure AIDS 
related stigma have been published, yet none of them measure the perceived stigma by persons 
living with HIV and AIDS in an African setting. A quantitative measure of HIV and AIDS 
stigma was developed in the studies that were conducted in five African countries: Lesotho, 
Malawi, South Africa, Swaziland and Tanzania from 2003 and 2006. It was developed in three 
phases: generating items, pilot testing and validating the instrument. Six factors were added: 
verbal abuse (8 items, alpha_0.886), negative self-perception (5 items, alpha_0.906), healthcare 
neglect (7 items, alpha_0.832), and social isolation (5 items, alpha_0.890), fear of contagion (6 
items, alpha_0.795) and workplace stigma (2 items, alpha _0.758). HIV and AIDS Stigma 
Instrument which is PLWA (HASI) provide evidence that supports adequate content and 
constructs validity (Holzemer et al. 2007). 
A cross-sectional study done in Kenya, discusses stigma measures, using multivariate logistic 
regression. They mention the anticipated HIV and AIDS stigma that showed a high 32% who 
anticipated the break-up of their relationship, and 45% who anticipated losing their friends. 
Hence women who anticipate male partner stigma are more than twice as likely to refuse HIV 
testing, after adjusting for individual level predictors (OR=2.10,95% CL:1.15-3.85). This 
quantitatively shows that anticipations as demonstrated in this study can be barriers to 
acceptance of HIV testing by pregnant women and developing of interventions to combat fear 
among women. The multi-item scales that are used to measure HIV and AIDS have been 
developed and demonstrated to be valid and reliable in Sub-Saharan Africa settings (Colombini 




2.7.1. Anticipated HIV and AIDS stigma items 
Anticipated stigma refers to the anticipation that one will personally experience specific types of 
stigma or discrimination due to HIV and AIDS. In a study conducted in Botswana where a nine-
item scale was used to measure construct, the respondent asked, ―Do you think any of the 
followings things might happen to you, if you were to test positive for HIV and others found out 
about your status?‖ Items included losing friends, being treated like an outcast by community, 
treated badly at work or school, physical abuse by spouse, being neglected by family and treated 
badly by professional healthcare workers (response will be yes or no, then coded1/0). A total 
anticipated stigma score was created by taking the mean of the responses for the nine items, for 
women who had non-missing data for at least six of the items. Reliability of this total score was 
found to be high in our sample (Cronbach‘s a = 0.86). 
 
2.7.2. Perceived community stigma and scales 
For perceived community stigma, the stigma scale developed by the National Institute of Mental 
Health Project was used and accepted to measure this construct. There are twenty-two items in 
this scale which people who have HIV are faced with and people are faced rejection from their 
homes by their families. Therefore people were asked to rate these statements on a four-point 
Likert scale from strongly agree to strongly disagree. The scale was previously tested in 
Tanzania, Zimbabwe, South Africa, and Thailand, and the three sub-scales were found to have 
acceptable reliability (Turan and Nyblade 2013). In a study conducted in the Netherlands by 
measuring health related stigma refers perceived stigma to fear of discrimination or, more 
generally to awareness of negative attitudes and or practices related to a particular condition. 
Accurate assessment of perceived stigma at both the individual and group level is an essential 
component of stigma measurement. The most promising instrument is the stigma scale 
(Famoroti, Fernandes et al. 2013). In a quantitative study (2012) in Ethiopia in the Ukraine; three 
items were used to measure in depth knowledge of HIV stigma and discrimination (SAD). 
Perceived institutional support (PIS) was measured by questions about availability of personal 
protection. Items used to measure stigma and discrimination were scored using a four-point 
Likert scale with a higher score indicating higher stigma and discrimination. Substantive validity 




A study conducted in the United States of America developed a questionnaire based on the 
results of field-testing measuring HIV stigma among health workers; the questionnaire was 
piloted in six sites namely China, Dominica, Egypt, Kenya, Puerto Rico and St. Kitts Nevis, and 
developed and tested, focuses four areas, such as fear of infection among healthcare facility staff. 
The questionnaire was created and researchers field-tested it in China (n=300), Dominica 
(n=335), Egypt (n=300), Kenya (n=350), Puerto Rico (n=301) and St. Kitts Nevis (n=307) 
(Nyblade, Jain et al. 2013). In the United States and India, several instruments have previously 
been tested with women living with HIV. The instruments asked about socio-demographic 
information, biologic health status, knowledge about HIV and stigma (Nyamathi et al. 2013). 
 
2.7.3. Stigma Scales 
South African community researchers write that the final AIDS-related stigma scale consists of 
nine items that tap a broad range of stigmatising beliefs (Kalichman et al. 2005). However, 
researchers also mention that there is no perfect tool to measure HIV stigma, thus Ekstrand and 
his colleagues provide four constructs stigma scales (Feyissa and Woldie 2012). 
 
2.7.3.1. Vicarious stigma 
Ten (10) Items which are similar to those assessed by the Enacted Stigma scale, but measured 
where participants had heard stories about other people living with HIV and AIDS being 
mistreated because of their infection. A sample item is, ―How often have your heard stories 
about people being refused medical care or denied hospital services because of their HIV?‖ Each 
item has a four-point response set that ranges from never to frequently. Internal consistency 
reliability as measured by Cronbach‘s alpha, was 0.85 for the scale in this sample (Nyamathi et 
al. 2013). 
 
2.7.3.2. Felt stigma  
This is when researchers discuss how a person would feel when the community give the attitudes 
to the people who are living with HIV and AIDS, by saying that they deserve their infections and 
also brought shame on their families. An example is ―In your community, how many people 
think that HIV-infected people have brought shame on their families? ―Then ten (10) items were 




2.7.3.3. Enacted Stigma 
This scale assesses the participants about their experience if they are HIV infected, such as being 
asked not to share utensils or plates with others family members, ten items are measured enacted 




2.7.3.4. Internalised Stigma 
This ten-item scale parallels the felt sigma scale, but it assesses the extent to which respondents 
believe that, as HIV infected people, they deserved to be stigmatised. Each item has a four-point 
response format varying from (1) not at all to (4) a great deal. For example, an item is: ―How 
much do you feel that you deserve to have HIV?‖ Reliability in this sample was 0.89, and 
internalised stigma scale all items begin with the words ―How much do you feel?‖ Previous 
studies used scoring for the HIV stigma scale items as follows: strongly disagree =1, disagree =2, 
agree =3, strongly agree =4 (Barbara Berger, 1996; United States Agency for International 
Development (USAID) Policy Project‘s, 2013 (Turan and Nyblade 2013). 
 
2.8. Women living with HIV stigma, and avoidant coping 
 Stigma affects negatively on employment, familial reputations and reluctance to be tested for 
HIV globally (Nyamathi et al. 2013). HIV stigma may be rooted in the belief that the burden of 
transmission is a bearer for having engaged in risky behaviour (French,  et al. 2015). Stigmas 
have a profound effect on people‘s decisions, behaviours, and outcomes and also reduce people‘s 
willingness to engage in HIV testing, treatment, and prevention. Studies have shown that stigma 
reduces people‘s participation in educational meetings and counselling, prevents risk reduction 
behaviour, and participation in programmes to prevent mother-to-child transmission (Psaros et 
al. 2015). Stigma has also been linked to a reduction in quality of life among people with HIV. 
HIV stigma and discrimination adversely affects every aspect of life for people living with HIV 
and their families. In many settings, HIV diagnosis can still be as devastating as the illness itself, 
leading to job loss, school expulsion, violence, social ostracism, loss of property, and denial of 
health services and emotional support (Darlington and Hutson 2016). People living in fear are 
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less likely to adopt preventive behaviour, come in for testing, disclose their status to others, 
access care and adhere to treatment, hence reducing stigma and discrimination can dramatically 
improve the lives of people affected by HIV (Churcher, 2013). 
2.9. Positive women’s perceptions of stigma in a healthcare setting 
The researchers of stigma suggest that poverty is an important driver of HIV stigma (Tsai, 
Bangsberg et al. 2013). In the Western Cape, South Africa, women revealed that they were being 
stigmatised in healthcare settings; while PMTCT programmes are effective, pregnant women 
were reluctant to follow-up due to high levels of stigma (Okoror, BeLue et al. 2014). The HIV 
and AIDS stigma is more severe for women than men, as they not only bear the burden of 
providing care for the sick loved ones, but they also bear the responsibility of being labelled as 
―disease carriers‖ (Psaros, Remmert et al. 2015). A study conducted in Khayelisha, a township 
setting in the Western Cape, South Africa, women revealed that in healthcare settings HIV-
positive people sit in their own section, which is not acceptable, and that even their files are 
different from other patients‘ files.  They also mentioned the pharmacy settings in the hospital, 
which has an isolated section for HIV-positive people, which forces the disclosure of status. 
There are separate rooms for HIV-positive people within the hospital which is turning into a 
stigmatised space for them (Okoror et al. 2014). 
 
In the study conducted in two areas, Khayelisha and Gugulethu, in Cape Town the researcher 
states different views about stigma in healthcare settings. The model shifts the focus from the 
individual to the cultural context of the behaviour, revealing how culture may influence these 
perceptions to reduce the stigma from women in healthcare settings, such as identifying 
behaviour that healthcare professionals need to avoid or embrace and identify healthcare 
protocols and policies that may enable or hinder care utilisation by HIV-positive women (Naidoo 
et al. 2014) 
 
A study conducted in India reported high rates of enacted stigma in rural women which derived 
from community and healthcare professionals (Nyamathi et al. 2013). South African studies 
indicated that 57% of women experienced stigma and discrimination from community and 




2.10. Stigmatisation and discrimination in HIV and AIDS 
Stigma could lead to delays and failures seek treatment, however the delay in the seeking of 
treatment may lead to the continuous spread of the disease within the community (Famoroti et al. 
2013). Discrimination may be described as a form of ―enacted stigma‖ or the negative acts that 
result from stigma which serve to devalue and reduce the life chances of the stigmatised 
(Famoroti et al. 2013). Most studies indicate that stigma is a barrier in healthcare settings (Tsai, 
Bangsberg et al. 2013). A study conducted in Russia revealed that the most vulnerable group 
being women was treated so badly so that they feel uncomfortable accessing health services and 
they mentioned that people who are HIV positive should be isolated from society and be 
punished for being positive (Dos Santos et al. 2014). 
2.11. Interventions to reduce stigma in women 
The National Rural Health Mission launched in India which targets the most under-served 
populations of rural women and children with the support of Asha or lay village women, who 
promote the health of pregnant women and infants, and was introduced to minimise stigma in the 
Indian women society (Nyamathi et al. 2013). However, there remains an ongoing need to 
develop interventions targeting rural women who are HIV-positive. The study conducted in India 
indicates that while interventions such as counselling and ongoing health education may reduce 
stigma, physicians, nurses, spiritual leaders should also be included to give health education 
including topics such as dealing with illness, the basics of good nutrition and easy ways of 
cooking tips, and reducing stigma by engagement in a life skills class, such as computer skills, 
marketing and embroidery (French et al. 2015). The literature indicated that, there are others 
ways to reduce stigma such as including family members and friends in discussion of treatment. 
However, at an individual level, interventions might seek to bolster instrumental social support 
by including family, friends and peers in treatment and services when feasible. At the community 
level, interventions might seek to enhance services which are available to people who are HIV-
positive, ensure that these services are accepting and supportive and are also being advertised in 
the community (Earnshaw et al. 2014). Studies suggest that until HIV stigma has been eradicated 
completely, it is critical to identify and bolster resources that enhance resilience to HIV stigma so 
that people can live full healthy lives, and also mention that community advocates, policy 
makers, and scientists have made significant strides towards eliminating HIV stigma since the 
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beginning of the epidemic, effectively reducing stigma in many areas of the world (Dos Santos et 
al. 2014). 
The authors articulated four interventions categories based on psychological conceptualisations 
of the stigmatisation process; information-based approaches such as written information in a 
brochure, skills building such as learning sessions to reduce negative attitudes, counselling or 
support groups for HIV-positive people and contact with affected groups like interactions 
between public and positive people (Stangl, et al. 2013). Most of the 22 studies reviewed 
attempted to increase the general tolerance or health providers‘ willingness to treat HIV-positive 
people by changing individual level of fear, attitudes or behaviours (Earnshaw et al. 2015). 
However complex problems require complex solutions (Dos Santos et al. 2014). Poverty and 
lack of reciprocal exchange are important drivers of stigma, as described in qualitative studies 
conducted in Sub-Saharan Africa (Tsai et al. 2013). 
 
According to the conceptual model of HIV stigma on five African countries, stigma is a complex 
process and it occurs within a context (French et al. 2015). A quantitative study conducted in the 
North-West Province, South Africa, focussing on people in healthcare settings, indicated that 
increasing the knowledge of HIV and stigma improved coping with stigma and empowerment 
and also improved voluntary HIV testing by nurses and was effective in reducing perceived 
stigma by women who are HIV-positive, improving their self-esteem (Yeji et al. 2014). HIV 
stigma reduction interventions targeting partners like programmes developed to empower women 
whose partners have died of HIV and AIDS to cope with the accompanying stigma (French et al. 
2015). Literature revealed that studies of HIV stigma reduction interventions targeting different 
groups of people via in-depth interviews conducted with people who are HIV positive, including 
experiences of people living with HIV, expressed a strong sense of shift in perception regarding 
HIV stigma experiences, and they reported feeling out of place and unsure initially, especially 
due to the imminent disclosure that was to take place; ―I felt lonely‖,‖ I was so afraid‖, and 
others reported being too scared to talk about HIV (Govender et al. 2014). The community 
interventions of stigma reduction were effective in the Setswana culture that is prominent in the 
North-West Province, where people who are HIV positive expressed a sense of being accepted 




2.12. PMTCT and levels of stigma among HIV-positive women 
The PMTCT programme was launched to improve maternal and child health, hence the 
reviewers suggest that PMTCT and maternal health services will not reach their full potential to 
save lives without addressing the context of women‘s lives, and in particular the continuing 
threats of stigma associated with positive HIV status in so many countries (Turan and Nyblade 
2013). In KwaZulu-Natal, South Africa, pregnant women reported that they hide their PMTCT 
medications from their boyfriends, family members, and employers, by doing so adherence is 
poor as evidenced from one of the regional hospitals (Ngarina et al. 2014). A study conducted in 
Kenya, stated that fear of stigmatisation among pregnant women was thought to account for 
lower rates of uptake of PMTCT services during childbirth compared to rates of uptake of 
antenatal care (ANC) services, which are often accessed before a mother's HIV status is known 
and for which participation does not result in identification as HIV-affected (Govender et al. 
2014). 
 
Stigma is prevalent in diverse contexts from Brazil to Zimbabwe. Stigma is strong in both higher 
HIV prevalence settings such as Botswana as well as in lower prevalence countries such as India. 
It also operates within families, communities, institutions such as healthcare facilities and places 
of employment, the media, and government policies, laws and legislation (Clouse et al. 2014). 
People living with HIV experience stigma in numerous forms. Social stigma excludes people 
living with HIV from family and community events, resulting in their loss of power and respect 
in the community. Physical stigma includes isolation (such as separate sleeping quarters in the 
home or a separate seating area in places of worship) and violence. Verbal stigma includes 
insults, taunts, blame, gossip and rumours. Institutional stigma includes job loss due to HIV 
status, eviction from housing, loss of educational opportunities and sub-standard healthcare 
(Earnshaw et al. 2014). In South Africa, fear of stigma has led people to grind their drugs into 
powder, which can result in inconsistent doses, and to avoid taking medicines in front of others 
(Okoror et al. 2014). 
 
Stigma associated with HIV is frequently layered over other forms of social disadvantage 
thereby accentuating the exclusion and devaluation of HIV-positive people (Akullian et al. 
2014). A study conducted in Cape Town revealed that participants spoke of how their partners 
rejected them after learning of their status. In a Vietnamese study, 60% of pregnant women who 
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refused HIV testing cited fear and discrimination as the dominant reasons (Psaros, 2015). In 
Kenya, pregnant women avoided delivering at a health facility or deliberately destroyed their 
antenatal cards, which included their HIV status, for fear of discrimination by health providers 
(Akullian et al. 2014). A survey of more than 1,000 healthcare professionals working directly 
with HIV patients in four Nigerian states found that 59% believed patients with HIV should be 
on a separate ward, 12% believed treatment of opportunistic infections wastes resources, and 
43% observed others refusing hospital admission to a person with HIV (Ebuy et al. 2015). 
 
2.13. Community perceptions of stigma in women who are HIV positive 
A study conducted in the Eastern Cape, Western Cape and KwaZulu-Natal, South Africa states 
that many women living with HIV are unable to access services, because they fear stigma and 
discrimination if their HIV status is disclosed, and also mention that violence against women, 
which has been defined as a form of gender based discrimination, also creates barriers for 
women living with HIV whom may fear the consequences of accessing HIV testing and 
medication (Yeji et al. 2014). In women who are living with HIV, the decision to disclose may 
be influenced by culture and community level stigma, hence the impact of community HIV 
stigma to women who are positive plays role in prevention to disclose (Ojikutu et al. 2016). A 
study conducted in Thailand, Brazil and Zambia stated that 45% of women living with HIV 
agreed perceived community stigma, their community belief that HIV is associated with being a 
sex worker and having multiple sexual partners (Ojikutu et al. 2016). A study conducted in 
Uganda stated higher prevalence of HIV among female youth, thus the community in Uganda 
associated having HIV with risky sexually behaviour to the female youth (Mafigiri et al. 2017). 
 
2.14. Stigma on Prevention of Mother- to-Child Transmission 
The literature indicates that there are divided sections in PMTCT such as HIV-related stigma in 
the context of PMTCT; neonatal survival, and health; healthy early childhood development 
nutrition; and marginalised groups; and child survival, however it is important to note HIV-
related stigma in the context of PMTCT, because it contributes to negative health outcomes for 
children and their parents, and disproportionally affects poor or marginalised groups (Turan and 
Nyblade, 2013). HIV-related stigma may be a barrier to uptake of care in pregnant women, hence 
also contributes to the gap between the availability of PMTCT services (Akullian et al. 2014). 
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The researchers suggest that PMTCT and maternal health services will not reach their full 
potential to save lives due to stigma related to women living with HIV in so many countries, 
however integration of PMTCT and other HIV services into maternal, neonatal, child, and other 
reproductive health services may be the solution (Turan and Nyblade, 2013). Limited access to 
and uptake of services for PMTCT as a result of the fear of or the experience of stigma and 
discriminations is a prominent example of how child survival can be influenced by stigma 
(Zuma, et al. 2016). There is a need to improve the self-esteem of women as they are being 
undermined in the societies; hence they are the umbrella of the community. By looking at the 
literature on PMTCT and HIV stigma among women, it shows that interventions to reduce 
stigma are needed, to improve child health outcomes in low- and middle-income countries 
(Psaros, et al. 2015). 
2.15. Conclusions 
Stigma and discrimination are barriers to access and uptake of health information and services 
(Naidoo et al. 2014).  Finding ways to increase HIV testing in South Africa may help to prevent 
the spread of HIV by increasing acceptance for HIV prevention behaviours and HIV treatment. 
However, the high rate of HIV stigma in South Africa is contributing to the low rate of testing. 
HIV stigma affects testing decisions in the community. A study conducted in the United States of 
America found that 38% of adults are very concerned about HIV stigma if they tested positive 
and 44% said that stigma influences their testing decision (Kamen et al. 2015). South Africans 
who have been not tested for HIV are shown to hold more negative views about HIV as 







Research methodology is the details of the procedures of data collection, analysis and writing 
(Williams, 2011). The section of methods and their application are always dependent on a 
number of factors, which include the purpose and objectives of the study, the nature of the 
phenomenon under investigation, underlying theory or expectations of the researcher, the 
intended audience and the experience of the researcher (Williams, 2011). 
Therefore, this study is focusing on perceived HIV related stigma among women, especially 
those who are living with HIV and AIDS. This chapter discusses the paradigm underpinning the 
study, population and sampling, the research methods used to collect data, and the rationale 
explaining why those methods have been chosen, how data was analysed, validity and reliability, 
and ethical considerations involved in the study. 
The purpose of this study is to explore and describe levels of perceived HIV related stigma 
among women living with HIV and AIDS in a selected regional hospital in the eThekwini 
District. The research methodology for this study is guided by the objectives of the study which 
are to explore and describe: 
1. Perceived levels of HIV related stigma among women living with HIV and AIDS. 
2.  Patterns of HIV disclosure among women living with HIV and AIDS. 
3. Inter-relationship between demographic variables and perceived levels of stigma among 
women living with HIV and AIDS. 
4. Inter-relationship between demographics and patterns of disclosure among women living 
with HIV and AIDS. 
5. Inter-relationship between patterns of disclosure and perceived stigma levels among 





3.2. The research paradigm for the study 
Paradigms are described as patterns of beliefs and practices used by researchers to regulate their 
disciplinary enquiry in order to accomplish their goals (Steward et al. 2008). Paradigm is also 
referred to as an overall philosophical framework of how scientific knowledge is produced. A 
paradigm includes the main assumptions, the questions to be answered in the investigation, there 
are two main competing paradigms in research theory, the positivist, mainly quantitative 
paradigm and the phenomenological, interpretive, mainly in qualitative paradigm of inquiry. This 
former was first established at the beginning of the 20
th
 century when social sciences were born 
and adapted to the positivist thinking of the natural sciences (Steele, Lindley et al. 1999). The 
researcher proposes to study perceived levels of HIV related stigma among women living with 
HIV within a positivist paradigm, as the positivist paradigm is aligned to quantitative research 
(Steele, Lindley et al. 1999) and this study uses a quantitative approach of a descriptive design. 
3.3. The positivist paradigm 
Positivist paradigm is also called the scientific paradigm. The purpose of research in this 
paradigm is to prove or disprove a hypothesis. It also includes an emphasis on the scientific 
method, statistical analysis, and generalizable findings. Furthermore, positivist research usually 
has a control and experimental group and pre-test and post-test method (Steele, Lindley et al. 
1999). The positivist researcher views science as value free and the world as objective. French 
philosophers believed that reality can be observed (Steele, Lindley et al. 1999). 
 
In addressing the ontological question which asks what the nature of reality is; the positivist 
researcher believes in the existence of an objective reality which can be understood, controlled 
and predicted by means of cause effects (Mack, 2010). The methodology question regarding the 
methods and techniques that can be used is addressed by positivists through the use of measuring 
instruments, such as a questionnaire and observations (Steward et al. 2008). Ontological 
assumptions and epistemological assumptions tend to overlap. As Mack (2010) points out ―to 
talk of the construction of the meaningful reality assumptions can be divided into two broad 
categories‖. 
 
The positivist paradigm is essential if nursing science is to substantiate claims regarding nursing 
care and the responses of clients in health and illness situations, provide explanatory models, and 
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test and generate theory (Mack, 2010). Thus, the researcher conducted this study within a 
positivist paradigm, which enables the researcher to objectively study perceived HIV related 
stigma and disclosure patterns among women living with HIV and AIDS in a selected regional 
hospital in the eThekwini District.  
3.4. Research Design 
A research design is described as a researcher‘s overall plan for obtaining answers to research 
questions or testing the research hypotheses (Polit et al. 2001). The research design serves as a 
blueprint for the researcher in planning and implementing the study to control factors that can 
affect its validity and reliability (Polit et al. 2001). The research design for this study was a 
explorative, quantitative research design used to explore and describe perceived levels of HIV 
related stigma and disclosure patterns among women living with HIV. The design questionnaire 
adopted from previous researchers was used to collect data. In this study, a quantitative approach 
was used; it also employs deductive reasoning to generate hunches that were tested in the real 
world (Polit, Beck et al. 2001). Quantitative researchers are aligned to the positivist paradigm 
and therefore gather empirical evidence which is inclined to objective reality that can be obtained 
through the senses (Polit et al. 2001). The quantitative researcher, as a positivist purist, employs 
cause and effect thinking, use of hypotheses and questions, measurements, observations, 
experiments and surveys to collect data and uses methods such as statistics for interpretation 
(Mack, 2010). By using a quantitative approach, the researcher was able to gain more insight into 
the perceptions of HIV related stigma among women living with HIV receiving maternal and 
child health services in a selected regional hospital. The researcher accurately describes and 
compares the findings between the groups and variables in the findings.  
3.5. Research setting 
The study was conducted in a selected hospital in KwaZulu-Natal in the eThekwini district of 
Durban, South Africa. The researcher looked at women, whose age category is between 20 to 35 
years, as 31.6% of Black African women living with HIV in South Africa and in KwaZulu-Natal 
is 16.9 % women of this age are living with HIV as they are sexually active from 18 to 35 years 
(Human Science Research Council, 2014 and National survey, 2014). The selected hospital is a 
regional hospital in the eThekwini district, and is one of the largest hospitals in KwaZulu-Natal 
province, which is the leading province for HIV and AIDS in South Africa according to 
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statistics. The hospital is government-funded (Ngidi, 2011), and  is a 1200 bed facility that serves 
the surrounding areas, up to and including part of the Eastern Cape. The hospital offers health 
services to the community at regional and district levels and has 17 clinics attached. The hospital 
is one of the sites for Prevention of Mother-to-Child Transmission (PMTCT) and has the largest 
crisis centre - now called the ―Place of Comfort‘. There are two clinics within the hospital which 
provide HIV services such as voluntary counselling and testing and ARV management.  
The hospital has maternity departments, which include the antenatal clinic and Prevention of 
Mother-to-Child Transmission (PMTCT). According to the monthly statistics register in the ante-
natal clinic in the selected hospital, the numbers for September 2015–February 2016 were, 1140, 
1329, 1300, 1061, 1085 and 1321 respectively. The researcher believes that the large number of 
pregnant women living with HIV who attended the antenatal clinic in the selected hospital is an 
appropriate setting for this study. On further count of the women attending the HIV clinic housed 
within the selected hospital, it shows a range of 265-310 women living with HIV and AIDS 
between the age of 20-35 years for the months of January to March 2016. 
Table 3.1. Monthly statistics (January – March, 2016) women living with HIV aged 22-35 
years 
Monthly Number of women 
January 2016 283 
February 2016 265 
March 2016 310 
3.6. Study population 
The study population refers to the aggregate or totality of those conforming to a set of 
specifications (Polit and Beck, 2012). The members of the population who meet the sampling or 
criteria are referred to as the target population and those whom the researcher has reasonable 
access to be referred to as accessible population (Elo and Kyngäs, 2008). The target population 
for this study was 286 women living with HIV and AIDS, the average number of women 
attending the HIV clinic in the selected hospital as per the hospital statistics for the three month 




3.7. Inclusion criteria 
1.  Women who are living with HIV and AIDS (WLWHA). 
2. WLWHA who have been booked in as patients within the selected hospital and clinic 
where HIV care was received 
3. WLWHA who are between the ages of 20-35 years. This age range is based on the 
national statistics for the highest prevalence of HIV in women in KZN (Shisana, Rehle et 
al. 2014). 
 
3.8. Sampling method 
In this study non-probability purposive sampling was used, this allowed the researcher to 
purposively select participants from the target population who had the desired inclusion criteria, 
which is a type of non-probability sampling. Purposive sampling is a form of non-probability 
sampling which allows the researcher to select study participants consciously based on the 
inclusion and exclusion criteria (Williams 2011). A sample size of 90 participants was deemed 
adequate for the study, following consultation with the statistician. The sample size of 90 from 
the target population produced a two-sided 95% confidence interval with a precision (half-width) 
of 0, 9 or 9% when the actual proportion is near 0.50-50% (assumes maximum variability given 
no prior estimates to factor into the calculation).  
3.9.Data collection 
3.9.1. Instrument for data collection 
Evidence for a study in the positivist paradigm is gathered according to a specified plan, using 
formal instruments to collect needed information, which is usually quantitative or numeric in 
nature (Polit, Beck et al. 2001). Data collection occurred over a one month period, to allow 
enough time to get the desired sample. In this study a structured self-reported questionnaire was 
developed (see Appendix: 6), the items for the instrument were sought from previous studies 
which measured HIV related stigma and disclosure patterns.  
The stigma scale by Holzemer et al (2007) was used to measure HIV related stigma. This 
quantitative measure of HIV and AIDS stigma was developed in a multinational study conducted 
in five African countries: Lesotho, Malawi, South Africa, Swaziland and Tanzania from 2003 
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and 2006. It was developed in three phases: generating items, pilot testing and validating the 
instrument. Six factors were added: verbal abuse (8 items, alpha_0.886), negative self-perception 
(5 items, alpha_0.906), healthcare neglect (7 items, alpha_0.832), and social isolation (5 items, 
alpha_0.890), fear of contagion (6 items, alpha_0.795) and workplace stigma (2 items, alpha 
_0.758). The HIV and AIDS Stigma Instrument (HASI), which is used to measure stigma in 
people living with HIV (PLWA) provides evidence that supports adequate content and construct 
validity (Holzemer et al. 2007). 
The first section includes the client‘s socio-demographic information such as age, marital status, 
level of education, and occupation. In addition, this section consists of some questions about the 
client‘s reproductive history including parity and the number of live children. This tool is used 
by other researchers for information on experience, opinion and how people with HIV are treated 
in the community. The second section includes information about the client‘s experiences or 
opinions and how people living with HIV are treated. There are four answers that need to be 
chosen; strongly disagree (SD), disagree (D), agree (A), and strongly agree (SA). The final score 
is an aggregate of the responses, with the lowest score indicating low perceived stigma and the 
higher score indicating higher perceived stigma. The scoring and use of the instrument was 
aligned to the authors of the scale (Holzemer et al, 2007 and Kalichman et al. 2005). The third 
section asks about the reaction of people towards others who are living with HIV within the 
family, community and a spouse or intimate partner. Section C. This section indicates how often 
people living with HIV are stigmatised. The score will be determined by the number of incidents 
(Steward et al. 2008). Asks about the HIV status: 0=never, 1=once or twice, 2=several times, 
3=most of the time 
3.9.2. Instrument validity 
According to Pilot and Beck (2001), validity is the degree to which an instrument measures what 
it is supposed to measure. It determines the extent to which an instrument reflects the abstract 
construct that the researcher is investigating (Williams, 2011). Therefore, the researcher in this 
study needs to establish the validity of the instruments adopted.  In this study the instrument 
measured the perceived levels of related stigma among women living with HIV and AIDS. 
There are different ways of assessing the validity of an instrument, such as criterion, content and 
construct validity (William, 2011). This study will be using content validity. Content validity is 
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the ability of the items on an instrument to represent all the major content of the construct being 
measured (William, 2011). This method was chosen to assess the validity of the items of the 
instrument in relation to the study objectives due to the availability of literature regarding the 
instruments, as reflected in Table 3.2. 
3.9.3. Instrument reliability and content validity of the instrument 
Instrument reliability is the ability of an instrument to consistently provide the same results in 
repeated measurements or occasions (Polit et al. 2001). Instrument reliability in a study is a 
major criterion for assessing its quality and adequacy (Burns and Grove, 2009. Reliability exists 
in degrees and is expressed as a form of correlation co-efficient, with 1.00 indicating perfect 
reliability and 0.00 indicating lack of reliability (Burns and Grove, 2009). The instrument used in 
this study has been previously tested showing strong Cronbach Coefficients as reflected in 
section 3.9. The instrument was translated by a language expert in isiZulu to allow participants 
who wanted to complete the questionnaire in isiZulu (see appendix 6 and 7). To ensure 
reliability, the translator used back translation from the isiZulu to English version and compared 
the items to ensure that the meaning of the words were not altered.  
Table 3.2. Content validity of the instrument 
Constructs Theoretical 
constructs 
 Item  
Literature 
contributing to the 
questionnaire 
Explore and describe 
levels of HIV related 
stigma among women 
Stigma  Section B Kalichman et al. 
2005; and 
Holzemer et al. 2007 
Explore and describe 
disclosure among 
women living with 
HIV  
Disclosure  Section A and C Do Sontos et al. 
2014;and Kartz et al. 
2013 
Explore and describe 
demographic 
variables and 
perceived levels of 
stigma. 
Demographic  Section A 1 and A 2 Stephenson et al. 
2009; and Shisana et 
al. 2014 
 







perceived HIV stigma 
Section B French et al. 2015 
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Explore and describe 
inter-relationship 
between disclosure 
and perceived stigma 
 
Context of women 
and stigma  
Section C Teklehaimanot et 
al.2016; and 
Ebuy et al. 2014 
 
3.10. Data collection procedure 
Every researcher collects data using one or more techniques. There are different types of data 
collection techniques in quantitative study, such as experiments, surveys and content analysis 
(Williams 2011). In this study, a survey data collection technique was used, as the researcher was 
obtaining information through the form of a self-reported questionnaire. 
Following ethical approval and gate keeper permission, data collection within the selected 
hospital commenced. Ethical approval was sought from the Biomedical Research Ethics 
Committee of the University of KwaZulu-Natal (Ethics number BE375/16). Following 
institutional ethical approval, gatekeeper permission was sought from the selected hospital (see 
appendix 2 and 3). The data were collected within a period of four weeks from 01 to 30 
November 2016. The researcher distributed the information letter and written informed consent 
was obtained from each participant prior to distribution of the data collection instrument (see 
appendix 5 and 6). On average it took participants between 20-25 minutes to complete the 
questionnaire. The participants were sampled and approached during their visit to the sampled 
hospital during their routine PMTCT visit, participants volunteered to complete the questionnaire 
(they were no participants who requested IsiZulu version) either before or after their consultation 
with the nurse or midwife. Participants who volunteered to participate in the study were provided 
a quiet space, which was an office within the Maternal and Child Health unit of the hospital, this 
ensured they had privacy while completing the questionnaire. A sealed box was available in the 
same venue, which allowed the participant to submit their completed questionnaire 
anonymously. The researcher was within the Maternal and Child Unit, but not in the same room 
during data collection, this was to ensure availability to the participants, should they need 
assistance or had queries. 
3.11. Ethical considerations 
Ethical issues in health related research has gathered much attention as an important topic in 
nursing research and professional practice (Bastida, Tseng, McKeever and Jack, 2010). In 
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nursing research, researchers are obligated to protect the rights of the study subjects. To ensure 
this right to protection, formal ethical approval was obtained from the Biomedical Ethics 
Committee (BE375/16) from the host University of the researcher; following which gatekeeper‘s 
approval was sought from the selected hospital management. (See Appendix 1 and 3).  
Participants require accurate information about a study to enable them to decide whether or not 
to participate (Grove et. al., 2013). The researcher ensured that the participants were adequately 
informed by explaining the purpose and significance of the study both verbally and on the 
information sheet. To ensure autonomy in the participant‘s choice to participate in the study, the 
information sheet and informed consent was provided in both English and isiZulu. The 
explanations were necessary because the principle of self-determination has it that prospective 
participants have the right to voluntarily decide on whether or not to participate in a study 
without any punishment or ill treatment (Polit and Beck, 2004) 
As it is unethical to allow unauthorized persons to have access to the raw data of a study (Grove 
et. al., 2013), the researcher kept the information obtained from the respondents confidential. To 
protect their rights to privacy, the participants were not required to disclose any personal, 
identifiable information. Questionnaires were anonymous and information gathered were kept 
confidential to further protect their rights to privacy. During the data collection process, the 
researcher informed the participant not to write their names on the questionnaires. Coding was used 
to eliminate names and other personal identification of respondents throughout the study process to 
ensure anonymity. 
 
It was clearly stated on the information sheet that participation in the study was voluntary and 
that they could withdraw from participation at any point of the study. They were also advised 
that they could seek clarification at any stage if they wished. The contact information of the 
researcher, the researcher‘s supervisor and UKZN ethical committee chair were provided for any 
questions or concerns that the participants may have regarding the study. The study‘s potential 
benefits, such as adding to the body of nursing knowledge, were also explained to the 




3.12. Data analysis 
Data was entered and subsequently analysed using SPSS version 21 from SPSS Survival Manual 
Fourth edition, (2011). Descriptive statistics such as frequencies, percentages, means, medians, 
standard deviations and interquartile ranges have been used to summarize the data. Descriptive 
and non-parametric tests were used to assess the levels of perceived stigma, disclosure patterns 
and inter-relationships between demographic variables and perceived HIV related stigma and 
disclosure patterns. Data analysis was conducted by the student in support by the statistician 
provided by the College of Health Sciences.   
3.13. Data management 
Data were collected by the researcher only, to ensure the confidentiality. After data analysis, all 
the questionnaires were stored in a secured and locked filing cabinet in the research supervisor‘s 
office in the School of Nursing and Public Health at the University of KwaZulu-Natal. The 
questionnaires will be kept for 5 years after completion of the study, and only the researcher and 
research supervisor will have access to the data. 
3.14. Summary of this chapter 
This chapter presented a discussion on the research paradigm which guided the study. It also 
presented the methodology, research design, the setting for the study, population for the study 
and the sampling procedure. The instrument for data collection, validity and reliability, and the 
procedure for data collection were also described. Issues concerning ethics in research, such as 






4. DATA PRESENTATION AND INTERPRETATION 
4.1. Introduction 
This chapter presents the analysis and interpretation of the results of the study. The results of the 
study are presented under the following sections: A 1, demographic data profile, A 2, 
reproductive history; B, perceived HIV stigma among women living with HIV; and C, disclosure 
patterns and levels of stigma. The results are summarized in tables with responses of strongly 
disagree, disagree, agree and strongly agree. 
4.2 Sample realisation 
The sample size for the study was 90 women living with HIV. A total of 90 questionnaires were 
therefore distributed to the participants, all 90 women were able to participate to the study and 
answered questionnaire. Descriptive and non-parametric tests were used to show the levels of 
perceived stigma, disclosure patterns and the inter-relationships between the demographic 
variables and perceived HIV-related stigma and disclosure patterns. 
4.3. Demographic characteristics of the sample 
The seven (7) variables under the demographic profile of the participants were age, marital 
status, ethnicity/race, employment, and level of education, where they lived and who they lived 
with. The participants were asked to indicate these variables so that the researcher could describe 
the characteristics of the participants and make correlations to establish the participants 
‘perceived levels of stigma, their patterns of disclosure, the relationship between the 
demographic and stigma, and the relationship between the demographic and disclosure. 
4.3.1 Age of the participants 
The ages were categorized to enable the researcher to determine the age distribution of the 
participants and to determine the influence of age on the perceived levels of stigma and patterns 
of disclosure. Ages 20-25 years were classified as category 1, ages 26-30 years were classified as 





Distribution of age categories of participants in years (n=90)    
There were three age categories in the demographic characteristics section of the questionnaire. 
The ages of the participants were ranging from 20-35 years. In age category 1, 38.9% (n=35) 
were aged from 20-25 years. In age category 2, 24.4% (n=22) were aged from 26-30 years, and 
those from the ages of 31-35 years (36.7%, n=33) fell into category 3. Therefore,  the highest 
number of women were aged from 20-25 years (38.9%), followed by age category 2 of 31-35 
year olds (36.7%), and the lowest number of participants (24.4%) were from age category 3, 
from 26-30 years of age. 
 
Figure 4.1: Age distribution 
4.3.2 Marital status of the participants 
The participants were asked to indicate their marital status as this enabled the researcher to 
determine whether marital status influenced the participants‘ disclosure of their HIV positive 
status or the level of stigma perceived by them. The findings showed that the majority of the 
participants were single (93.3 %, n=84); (2.2%, n=2) of them were married; and those living with 
partners but not married accounted for (4.4%, n=4) of the sample. None of the participants were 
separated or divorced. 




















The participants were requested to disclose their employment status, in order for the researcher 
to determine whether this had an influence or relationship with the disclosure of their HIV or the 
level of stigma perceived by the participants The findings showed that the majority of the 
participants were unemployed (81.1%, n=73), while only 18.9% (n=17) were employed. In 
instances where the participants indicated that they were unemployed, they were requested to 
indicate who the breadwinner was at home. The majority of the unemployed participants (44.4%, 
n=40) indicated that they were themselves the breadwinners in the home, and indicated that their 
income was derived from government grants and informal trading (selling on the street). Of the 
remaining unemployed participants, 40.0% (n=36) were supported by their mothers, 11.1% 
(n=10) were supported by their fathers, and 4.4% (n=4) were supported by an aunt. 
4.3.4 Level of education 
The participants were asked to indicate their level of education in order to enable the researcher 
to determine the varying level of education of the participants and whether this has an influence 
or relationship with disclosure of HIV or level of stigma perceived by the participants. The 
findings showed that the majority of the participants had completed high school (grade 12) 
(58.9%, n=53) and 17.8% (n=16) of the participants had completed secondary school (grade 10). 
A further 20.0% (n=18) of the participants had a tertiary education and 3.3% (n=3) had only 
completed primary school. 
4.3.5 Residence 
The participants were asked to indicate their residence in order to enable the researcher to 
determine the varying residence of the participants and whether this has an influence or 
relationship with disclosure of HIV or level of stigma perceived by the participants. The findings 
showed that participants who lived in rural areas accounted for 51.1% (n=46) and 48.9% (n= 44) 
lived in urban areas. The participants were then asked to disclose whether or not they lived with 
anyone, as the researcher wanted to determine the influence of these residential factors on the 
disclosure of their HIV positive status and their perception of the level of stigma associated with 
their illness. 87.8% (n=79) of the participants lived with their family members; 11.1% (n=10) 




Table 4.1: Demographics characteristics 1(n= 90) 
 Frequency  Percentage 
Age category: 
1: 20-25 years 
2: 26-30 years 



















































Level of education: 
Completed primary school 





































4.4 Section A 2: Reproductive history 
The following section discussed about the participant‘s reproductive history, see below 
4.4.1 Number of pregnancies 
The participants were asked to indicate the number of pregnancies in order to enable the 
researcher to determine the varying number of the pregnancy of the participants and whether this 
has an influence or relationship with disclosure of HIV or level of stigma perceived by the 
participants. The findings show that participants who were first pregnant accounted for 27.8% 
(n=25), participants who had their second pregnancy accounted for 40.0% (n=36), participants 
who were pregnant for a third time accounted for 30.0% (n=27), and participants who had more 
than four pregnancies accounted for 2.2% (n=2).  
4.4.2 Number of children 
In response to the question on the number of live children, 15.6% (n=14) indicated that they had 
no living children and were on their first pregnancy; 32.2% (n=29) indicated that they had one 
child; 31.1% (n=28) had two children; 20.0% (n=18) had three children; while 1.1% (n=1) had 
four (or more) children. The researcher aimed to determine if the number of children that the 
women had impacted on their disclosure of their HIV status or on their perceived level of stigma 
associated with their disease. 
4.4.3 Place of delivery 
The participants were asked to indicate the place of delivery in order to enable the researcher to 
determine the varying of the place of delivery whether this has an influence or relationship with 
disclosure of HIV or level of stigma perceived by the participants. The findings showed that 
participants who were delivered at home accounted for 1.1% (n=1), participants who were 
delivered in the hospital accounted for 82, 2% (n=74), participants who were delivered in health 
care centre accounted for 3.3% (n=3), participants who were delivered in private clinics 
accounted for 1.1% (n=1), and participants who were having no previous delivery accounted for 
11.1% (n=10). 
4.4.4 Antenatal visits 
The participants were asked to indicate their number of present antenatal visits as they would 
have been exposed to information regarding HIV, anti-retroviral treatment and prevention of 
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mother-to-child transmission of the disease in these clinic settings; and the researcher wanted to 
determine if varying numbers of antenatal clinic visits influenced their disclosure of their disease 
or if it impacted on their perception of the stigma attached to the disease in any way. The 
findings showed that 8.9% (n=8) of the participants had visited an antenatal clinic once prior to 
the study, and 12.2% (n=11) of the participants had visited an antenatal clinic twice. A further 
12.2% (n=11) had visited a clinic three times, 18.9% (n=17) had visited an antenatal clinic four 
times, and 46.2% (n=42) indicated that they had visited an antenatal clinic more than five times. 
Table 4.2: Reproductive history 
 Frequency(n) Percentage % 








































































4.5. Section B: Perceived levels of stigma (score items)  
Section B of the questionnaire consisted of 19 items/statements that were developed to elicit 
information on the perceived level of stigma among women living with HIV. There were four 
options from which the participants were required to choose only one. For the first question, the 
options were strongly disagree (SD), disagree (D), agree (A) and strongly agree (SA).  
Table 4.3: Perceived levels of HIV stigma  
Variables   SD D A SA 
1. No one in my 
family knows 
that I have HIV 
35(38.9%)    35(38.9%)     9(10.0%)    11(12.2%)       
2. I feel guilty 
because I have 
HIV           
27(30.0%)     38(42.2%)     9(10.0%)    15(16.7%) 
3.People‘s 
attitudes about 
HIV make me 
feel worse about 
myself               
34(37.8%)     22(24.4%)      9(10.0%)    25(27.8%)    
4.Telling 
someone I have 
HIV is risky 
33(36.7%)     28(31.1%)      11(12.2%) 18(20.0%)    
5. People with 
HIV lose their 
jobs when 
employers find 
out                   
30(33.3%)      41(45.8%)      7(7.8%)       12(13.3%)      
6. I work hard to 24(26.7%)        39(43.3%)       7(7.8%)     12(13.3%)    
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keep my HIV 
   status  a secret                
7. I feel I am not 
good as others 
    because I have 
HIV                               
39(43.3%)        32(35.6%)        7(7.8%)      12(13.3 
8. I never feel 
ashamed of HIV 
18(20.0%)         29(32.2%)        13(14.1%)    30(33.3%) 
9. People with 
HIV are treated 
like outcasts 
22(24.4%)         38(425.2%)      10(11.1%)    20(22.2%) 
10. Having HIV 
makes me feel 
dirty   
34(37.8%)         38(42.2%)         10(11.1%)    8(8.9%) 
11. Most people 
believe that a 
person  
who has HIV is 
dirty.                              
23(25.6%)     29(32.2%)       16(17.8%)     22(24.4%) 
12. I prefer to 
avoid having 
friends  
   because I have 
HIV 
36(40.0%)       45(50.0%)      4(4.4%)      5(5.6%)    
13. Since 
learning I have 
HIV, I feel set 
apart 
 
29(32.2%)       47(52.2%)     6(6.7%)     8(8.9%)   
14. Most people 
think that a 




 HIV is being 
punished by God               
15. Having HIV 
makes me feel 
 that I‘m a bad 
person 
35(38.9%)        
 
39(43.3%)       5(5.6%)     11(12.2%)90 
16. Most people 
with HIV are 
rejected 
when others find 
out 
14(15.6%)      28(31.1%)     14(15.6%)     34(37.8%) 
17. I am very 
careful who I tell 
 that I have HIV   
8(8.9%)       
 
17(18.9%)       30(33.3%)     34(37.8%) 
18. Some people 




21(23.3%)         
 
37(41.1%)     6(6.7%)       26(28.9%)  
19. Since 
learning I have 
HIV, I worry to 
be discriminated                                
  23(25.6%)                             33(36.7%)     5(5.6%)      29(32.2%) 90 
 
Table 4.3 indicates that the majority of the participants strongly disagreed and disagreed with the 
statement that no one in their family knew that they had HIV (n=35, 38.9% respectively), in 
comparison to n=9 (10.0%) of the participants who agreed and n=11 (12.2%) who strongly 
agreed with the statement.  
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The participants n=27 (30.0%) strongly disagreed, and n=38 (42.2%) disagreed with the 
statement that they felt guilty because they had HIV; compared to n=9 (10.0%) of the 
participants who agreed and n=15 (16.7%) of the participants who strongly agreed. 
As for the statement that people‘s attitudes about HIV made them feel worse about themselves, 
the majority of the participants (n=34, 37.8%) strongly disagreed with it and another n=22 
(24.4%) disagreed with it; compared to a few of the participants (n=9, 10.0%) who agreed, and 
another n=25 (27.8%) who strongly agreed with the statement.  
In response to the statement ―Telling someone that I have HIV is risky‖, the majority of the 
participants (n=33, 36.7%) strongly disagreed and n=28 (31.1%) disagreed; compared to a few of 
the participants (n=11, 12.2%) who agreed, and n=18 (20.0%) strongly agreed that this was 
indeed the case. 
The majority of the participants (n=30, 33.3%) strongly disagreed with the statement that people 
with HIV lose their jobs when their employers found out about their HIV status. n=41 (45.8%) 
disagreed compared to a few participants (n=7, 7.8%) who agreed, and those (n=12, 13.3%) who 
strongly agreed that this was the case. The majority of the participants (n=39, 43.3%) disagreed 
and a further n=24 (26.7%) strongly disagreed; while n=20 (22.2%) agreed and another n=7 
(7.8%) strongly agreed with the statement that they worked hard to keep their HIV status a 
secret.  
In response to the statement ―I feel I am not as good as others because I have HIV‖, the 
participants had the following to say: The majority of them (n=39, 43.3%) strongly disagreed 
that they felt that way, while=32 (35.6%) merely disagreed. n=7 (7.8%) of the participants felt 
that way and agreed, while a further n=12 (13.3%) strongly agreed that they felt that way. 
―I never feel ashamed of HIV, n=18 (20.0%) of the participants strongly disagreed with this 
statement, and n=29 (32.2%) disagreed with it; whereas the majority (n=30, 33.3%) strongly 
agreed with the statement and n=13 (14.4%) agreed. The majority of the participants (n=38, 
42.2%) disagreed, compared to the few participants (n=10, 11.1%) who agreed with the 
statement that people with HIV were treated like outcasts.  
The majority of the participants (n=34, 37.8%) disagreed that having HIV made them feel dirty, 
and n=38 (42.2%) strongly disagreed with this statement; however, a few of the participants 
64 
 
(n=10, 11.1%) agreed that they felt dirty because of their disease and a further=8 (8.9%) strongly 
agreed that they felt that way. 
 As to the statement that most people believed that a person who had HIV was dirty; the majority 
of the participants (n=29, 32.2%) disagreed, n=23 (25.6%) strongly disagreed, n=16 (17.8%) 
agreed and n=22 (24.4%) strongly agreed with it, and n=45 (50.0%) disagreed with the 
statement, ―I prefer to avoid having friends because I have HIV‖. Some participants, however, 
tended to avoid having friends, indicated by the n=4 (4.4%) who agreed with this statement, and 
n=5 (5.6%) who strongly agreed. In response to this statement ―Since learning I have HIV, I feel 
set apart and isolated from the rest of the world‖ the majority of the participants (n=29, 32.2%) 
strongly disagreed, n=47 (52.2%) disagreed, n=6 (6.7%) agreed and n=8 (8.9%) strongly agreed 
with it.  
The majority of the participants (n=33, 36.7%) strongly disagreed, n=31 (34.4%) disagreed, 
n=20 (22.2%) agreed and n=6 (6.7%) strongly agreed with the statement that most people 
thought that a person with HIV was being punished by God. The majority of the participants 
(n=39, 43.3%) disagreed with the statement, ―Having HIV makes me feel that I am a bad 
person‖. n=35, 38.9%) strongly disagreed with the statement, n=5 (5.6%) agreed with it and 
n=11 (12.2%) strongly agreed with the statement 
For item 16 (most people with HIV are rejected when others find out), the findings showed that 
the majority of the participants (n=34, 37.8%) strongly agreed with the statement, and n=28 
(31.1%) disagreed with the statement; however, n=14 (15.6%) responded equally with ‗strongly 
disagreed‘ and ‗agreed‘. A few of the participants (n=8, 8.9%) strongly disagreed, and=17 
(18.9%) disagreed; while several of them (n=30, 33.3 %) agreed and the majority (n=34, 37.8%) 
strongly agreed with the statement that they were very careful who they told that they had HIV.  
For item number 18 (some people who know that I have HIV distance themselves) the 
participants responded as follows: n=37 (41.1%) disagreed, n=21 (23.3%) strongly disagreed, 
n=6 (6.7%) agreed and n=26 (28.9%) strongly agreed with the statement. 
For item number 19 (Since learning I have HIV, I worry about being discriminated against) the 
participants responded as follows: n=23 (25.6%) strongly disagreed, n=33 (36.7%) disagreed, 
n=5 (5.6%) agreed, and n=29 (32.2%) strongly agreed with the statement. 
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4.6 Section C: HIV disclosure 
This section discusses the participants‘ disclosure regarding their HIV positive status. When 
asked if they had disclosed their HIV status to anyone, n=63 (70.0%) said Yes‘ they had 
disclosed their HIV status in comparison to the n=27 (30.0%) participants who responded with 
‗No‘ (see Figure 4.2).  
 
Figure 4.2: HIV disclosure 
4.6.1 Stigma events related to disclosure 
In this section the participants were requested to quantify the number of events related to stigma 
and HIV. There were four possible scoring rates: 0= never, 1=once or twice, 2=several times and 
3=most of the time. Participants were requested to rate these patterns of disclosure so that the 
researcher could rate the level of stigma perceived by the participants. Table 4.5. Highlights 
eight items relating to the stigma and disclosure. The table shows that the majority of the 
respondents did not encounter any stigma following their disclosure (65.6% to 80%), while only 


















Table 4.5: Stigma and disclosure 
Items Never Once or twice Several times Most of the 
time 
1.Someone scolded me 
 
66(73.3%) 15(16.7%) 4(4.4%) 4(4.4%)  
 
 














4.I was told I have no future 
 
63(70.0%) 12(13.3%) 9(10.0%) 6(6.7%) 
 
5.I was told that God is 
punishing me 
72(80.0%) 11(12.2%) 4(4.4%) 3(3.3%) 
 
6.I was called bad names 
 
59(65.6%) 13(14.4%) 10(11.1%) 8(8.9%) 
 
7.Someone mocked me when I 
passed by 
 
71(78.9%) 8(8.9%) 7(7.8%) 4(4.4%) 
8.People sang offensive songs 
when I passed by 
 





4.7. Inter-relationships of Stigma, Disclosure and Demographic variables 
The following tests were conducted in order to answer the research questions: Frequencies and 
descriptive statistics, Cronbach‘s alpha, Independent Sample t-tests and ANOVA, Pearson 
product-moment correlations, and standard multiple regressions.  
Firstly, the demographic characteristics are presented, and descriptive statistics are presented to 
determine the normality of the distribution. The results of the Pearson product-moment 
correlations are presented to determine the relationships of the variables. The results of the 
Independent Sample t-tests and ANOVA are also discussed to determine the differences in the 
mean scores between groups of the dependent variables. 
4.7.1. 
 Independent t-test of the demographics on stigma 
Table 4.6 illustrates the results of the descriptive statistics of all the measures used in the study. 
Descriptive statistics provide the information concerning the normality of the distribution of the 
scores.  
Table 4.6: Results of the Independent t-test of the demographics on stigma 





40.7       7.8 
40.3        9.5 
0.2 0.9 




41          10.5 








40.5       9.5 
40          4.8 
0.17 0.52 
 
The Independent t-test was performed to test the two groups for each variable, e.g. employed and 
unemployed, and their relationship to stigma. Table 4.6 shows that there was no significant 
impact on stigma by these demographics, however, the results indicated that employed 
participants experienced slightly more stigma (mean 40.7+SD 7.8) than the unemployed (mean 
40.3+SD 9.5), with a sig-value of 0.9. Residents in rural areas experienced slightly higher levels 
of stigma (mean 41+SD10.5) than those residing in an urban area (mean 39.7+SD7.5) and (sig-
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value 0.52). People living with family (mean 40.5+SD 9.5) experienced slightly more stigma 
than those who lived with a friend (mean 40+SD 4.8) and (sig- value 0.52). 
4.7.2 Independent t-test of demographics on disclosure 
The Independent t-test was performed to test the two groups of each variable and their 
relationship to disclosure (see Table 4.7). 
Table 4.7: Results of the Independent t-test of the demographics on disclosure 





2.7        3.6 








2.7        4.2 








3.9         5.1 
2             3 
1.7 0.1 
 
The results of the Independent t-test to test the two groups for each variable e.g. employed and 
unemployed and their relationship with disclosure showed no significant relationship between 
disclosure and any of these demographics. Participants who were unemployed disclosed their 
status more (mean 3.8+SD 5.2) than those who were employed (mean 3.8+SD 5.2), with sig-
value of 0.3. Those living in an urban area (mean 4.5 +SD 5.6) disclosed their status more than 
those in the rural areas (mean 2.7+SD 4.2) and (sig-value 0.1). The participants living with 
family members (mean 3.9 +SD 5.1) disclosed their status to these co-habitants more than those 







4.7.3 ANOVA of the demographics on stigma 
Analyses of variance (ANOVA) were used to compare the mean scores of more than two groups 
(see Table 4.8).  
Table 4.8: ANOVA of the demographics on stigma 







39.6      7.8 
41.5     11 
40.3     9.2 
0.3 0.7 







40.2      9.2 
38.5      13.4 












40.7      10.6 
37.1       6.4 
45.3      21.1 





















39          8.9 
 
                 
42,5         6,9 
 
 
40.5        9,6 
 
3.11       9.7 
0.3 0.6 
 
There were no significant differences in the results. Table 4.8 shows that the participants 
between the ages of 26-30 years experienced more stigma (mean 41.5+ SD= 11). In the analysis 
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of variance performed on marital status, results showed higher stigma for participants who were 
unmarried but living with their partners (mean=42.7+SD=7.6), single (mean=40.2+SD=9.2), 
however married participants experienced less stigma (mean=38.5+SD=13.4). In terms of 
breadwinners and stigma, the results showed that the participants who were being supported by 
an aunt experienced a higher level of stigma (mean=45.3+SD=21.1). The participants who 
completed secondary school experienced more stigma (mean=42.5+SD=6.9) than those with the 
other education levels. 
4.7.4 ANOVA of the demographics on disclosure 
The Analysis of Variance (ANOVA) was used to compare the mean scores of the two groups of 
each demographic variable on disclosure (see Table 4.9). 
Table: 4.9: ANOVA of the demographics on disclosure 
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In Table 4.9, the ANOVA results showed that there were no significant differences in the results. 
Participants between the ages 26-30 years disclosed their status (mean=5.1 +SD=6.6) more than 
the other age groups. Participants who were single disclosed their HIV positive status more than 
the others (mean 3.7+SD 5.0), while married participants (mean 2.5+SD 2.1) were poor at 
disclosing their HIV status. The results showed that the participants who were supported by their 
mothers disclosed their status to them more (mean 4.8+SD 5.6) than those who were supported 
by their fathers (poor level of disclosure (mean 1.9+SD3.8). With regards to the participants‘ 
level of education; those who had completed secondary school disclosed their HIV status more 
(mean 4.7+SD5.1) than those that had not. 
4.7.5 ANOVA of reproductive history on stigma 
Analysis of variance (ANOVA) was used to compare the mean scores of more than two groups 
of reproductive history on stigma (see Table 4.10).   
Table 4.10: ANOVA of reproductive history on stigma 
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40.4      9.2 
39.0    10.1 
 
40.0     0 
 
40.0    10.5  
0.7 0.10 










40.1     12.7 
38.9      9.1 
38.1     8.4 
43.9      12.3 
39.9      6.8 
0.4 0.5 
 
Table 4.10. Shows the correlation of the results of stigma and reproductive history. Participants 
who had been pregnant more than three times experienced more stigma (mean 45.0+SD7.0) than 
those with fewer pregnancies. Those participants on their second pregnancy also experienced 
stigma (mean 43.1+SD7.6). The ANOVA test showed that participants who had more than four 
children experienced more stigma (mean 50.0 +SD 0) than those with fewer children, and that 
participants who delivered in a hospital reported more experience of stigma (mean 40.4 +SD 9.2) 
than those who had delivered elsewhere. Participants who had attended an antenatal clinic more 





4.7.6 ANOVA of reproductive history on disclosure 
Table 4.11 outlines the results of the ANOVA of reproductive history on disclosure.  
Table 4.11: ANOVA of reproductive history on disclosure 
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The results in Table 4.11 indicate that there was no significant correlation between disclosure 
and reproductive history, as those participants on their first pregnancy disclosed their status 
(mean 5.8+SD 6.3) more than those with a higher number of pregnancies, as indicated by the 
results for the second pregnancy (mean 3.1+SD 4.3), the third pregnancy (mean 2.5+SD 3.8), 
and those on their fourth pregnancy or above (mean 0.5+SD 0.7). As for the variable of the 
number of children, participants who had no children born yet disclosed their status more (mean 
7.0+SD 6.2) than the rest of the participants.  
4.8 Correlations between demographics and stigma 
Table 4.12 shows the results of the relationship between the scales gained from the analyses of 
the Pearson product-moment correlation coefficient. The Pearson product-moment correlation 
coefficient was calculated to determine the strength and direction of the relationships between 
the measures of the study. 
Table: 4.12.  Results of correlations between demographics and stigma 
Variable R Sig-value 
Age and stigma 0.033 0.755 
Marital status and stigma 0.051 0.632 
Employment and stigma -0.019 0.857 
Breadwinner and stigma 0.007 0.951 
Levels of education and stigma -0.114 0.283 
Person lived with and stigma 0.086 0.419 
Times Number of pregnancy and 
stigma 
-0.104 0.329 
Number of children and stigma -0.688 0.411 
Place of delivery and stigma -0.029 0.784 
Number of antenatal visits and stigma 0.040 0.708 
Correlation is significant at the 0.01 level (2 tailed) 
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Pearson‘s correlation was performed to establish the relationships between the age of the 
participants and stigma. Table 4.12 shows that there was positive weak correlation (r=0.033) 
between this variable and stigma. The correlation test between marital status and stigma showed 
that there was positive weak correlation (r=0.051) between the two. The relationship between 
employment and stigma was negative (r=-0.19), while the correlation between breadwinner 
status and stigma was very weak (r=0.007). There was no correlation between the levels of 
education and stigma (correlation was negative=-114), whereas there was positive weak 
correlation between the person that the participant was living with and stigma (r=0.086). 
 The number of pregnancies showed a negative correlation with stigma (r=-104); the correlation 
between the number of children and stigma was also negative (r=-688); as was the correlation 
between the place of delivery and stigma (r=-029). The relationship between the number of clinic 
visits and stigma, however, showed a positive weak correlation (r=0.040). The results thus 
indicated that the relationship between demographics and stigma was very weak and negative, 
and therefore was not significant. 
4.9 Correlations between demographics and disclosure 
In order to establish the relationship between demographics and disclosure patterns, Spearman‘s 
correlations were conducted (Table 4.13). 
Table: 4.13: Correlations between demographics and disclosure 
Variable R Sig-value 
Age and disclosure 0.086 0.418 
Marital status and disclosure -011 0.915 
Employment and disclosure 0.090 0.400 
Breadwinner and disclosure -136 0.201 
Level of education and disclosure -036 0.733 
Person lived with and stigma -143 0.180 
Number of pregnancy and stigma -263 0.012 
Number of children and stigma -212 0.045 
Place of delivery and stigma 0.205 0.053 
Number of antenatal visits and stigma -048 0.651 
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Correlation is significant at the 0.05 level (2 tailed) 
The results in Table 4.13 above show that there was a positive weak relationship (r=0.086) 
between the age of the participant and disclosure. It is also shows that there was negative 
correlation between marital status and disclosure (r= -0.011). There was a positive weak 
correlation between employment and disclosure (0.090), while the correlation between the 
breadwinner and disclosure was negative (r= -0.136), as was the correlation between the level of 
education and disclosure (r= -0.036). The relationship between disclosure and the person/people 
that the participants lived with was negative (r= -0.143), as was the correlation between 
disclosure and the number of times the participants had been pregnant (r= -0.263). The 
correlation between disclosure and the number of children was also negative (r= -0.212); 
however, the correlation between disclosure and the place of delivery showed that there was a 
positive weak relationship (r=0.205); while the number of antenatal visits also had a negative 
relationship with disclosure (r= -0.048). There was therefore no significant correlation between 
the participants‘ demographics and their disclosure.  
4.10 Correlation between stigma and disclosure 
Table 4.14 reflects the correlation between stigma and disclosure.  
Table 4.14: Correlation between stigma and disclosure 
Variable R Sig-value 
Stigma and disclosure 0.18 0.1 
 
In table 4.14, the tabulated results show that there was no significant correlation between stigma 
and disclosure rate on the part of the participants: There was only a weak positive correlation 
(r=0.18+p= 0.1). 
4.11 Summary of the chapter 
This chapter featured a detailed description of the analyses and interpretation the data collected 
for the study. The results were presented in tables and interpreted thereafter, and the analyses 
were based on the data from the 90 participants that participated in the study. The findings 
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showed that the majority of the participants were aged between 20-25 years (38.9%, n=35). In 
relation to gender, all participants were females, most of them were single (93.3%n=84).  
The results showed that the majority of the participants were unemployed (81.1%, n=73), that the 
majority of them had completed high school high school (58.9%, n=53), and that the majority of 
them lived with their families (87.8%, n=79). The majority of the participants had delivered in a 
hospital accounted for (82, 2%, n=74). 
There were five objectives tested: 
1. The levels of HIV related stigma among women living with HIV; the information that 
was given by the participants on their perceived levels of HIV stigma among women 
indicated that stigma was high.10 items on the questionnaire indicated this: 2, 4, 6, 7, 
10, 12, 13, 15, 17, and 19 had results of ‗strongly agreed‘ and ‗agreed‘, ranging from 
(n=27 (30.2%) to n=47 (52.2%). 
2.  Patterns of HIV disclosure among women living with HIV: The results indicated that 
most of the participants (n=35, 38, 9%) ‗Strongly disagreed‘ and ‗disagreed‘ with the 
statement, there is no one in the family knew that they had HIV indicating that the 
women only disclosed their status to their family member. 
3. The inter-relationship between the demographic variables and the perceived levels of 
stigma among women living with HIV: The results indicated that the relationship 
between the demographics and stigma was very weak and negative, and was therefore 
not significant. 
4. The inter-relationship between the demographic variables and the patterns of 
disclosure among women living with HIV: No significant relationship was found 
between them. 
5. Inter-relationship between patterns of disclosure and the perceived stigma levels 
among women living with HIV: The results showed that there was no significant 
relationship between stigma and disclosure in responses of the participants; there was 
only a positive weak correlation(r=0.18+p= 0.1). 
 
Correlation analysis performed showed a weak positive correlation between demographics and 
stigma. The correlation between demographics and disclosure patterns was also a weak positive. 
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The negative weak correlation also identified between the variables was also not significant. The 
results of the study showed that stigma still existed among women who were living with HIV, 
hence, most of the women only disclosed their HIV status to their immediate family members. 
4.12 Conclusion of the chapter 
In conclusion, the results of the study showed that stigma was still perceived among women 
living with HIV and that this affected their disclosure patterns, although there was support from 
family and the community for those who had disclosed their HIV status. Literature has indicated 
that disclosing of the HIV status to a partner and to family may lower the risk of infection and 





5. DISCUSSION, RECOMMENDATIONS, LIMITATIONS AND CONCLUSION 
5.1 Introduction 
The aim of this study was to explore and describe perceived levels of HIV related stigma and 
disclosure patterns among women living with HIV in a selected regional hospital in the 
eThekwini District of KZN. This chapter presents a discussion of the literature reviewed in 
relation to the findings of the study described in chapter four. This chapter also presents the 
summary of the study and the implication of stigma and disclosure patterns among women, 
recommendations for future research and the conclusion of the study. 
In order to address the research questions of the study, the researcher formulated the following 
objectives:  To explore and describe: 
 The perceived levels of HIV related stigma among women living with HIV and AIDS. 
 The patterns of HIV disclosure among women living with HIV and AIDS. 
 The inter-relationship between the demographic variables and the perceived levels of 
stigma among women living with HIV and AIDS. 
 The inter-relationship between the demographic variables and the disclosure patterns 
among women living with HIV and AIDS. 
 The inter-relationship between the patterns of disclosure and the perceived stigma levels 
among women living with HIV and AID. 
A quantitative descriptive, explorative design was used to explore and describe the perceived 
levels of HIV related stigma among women living with HIV. The design of the questionnaire 
was adopted from previous researchers and used to collect data. This instrument allowed the 
researcher to obtain information about the demographic characteristics of the participants and the 
levels of stigma and disclosure patterns.  
5.2 Demographic characteristics of the participants 
The demographic variables of the study were age, marital status, employment, ethnicity or race 
and breadwinner status, the level of education, residence and reproductive history. The 
researcher did not discuss about ethnicity or race because all the participants in this study were 
Black African women. 
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5.2.1 Age of the participants 
The findings of this study showed that the majority of the participants were aged between 20-25 
years. The mean age of the participants and the standard deviation (mean± SD) were 1.1 ±0.870. 
The findings of this study were similar to the study of Shisana et al. 2014), who concluded that 
participants of this age group were likely to experience stigma and were reluctant to disclose 
their HIV status. This could also have signified that at this younger age (20-25 years), they were 
not in serious relationships and thus did not have much experience of relationships. The 
perceived level of community was also seen to influence older women, as they were less likely to 
disclose their HIV status, according to Ojikutu et al. (2016).  
5.2.2 Marital status of the participants 
The findings of this study showed that the majority of the participants were single (93.3%, 
n=84), those who were married accounted for 2.2% (n=2) and those living with their partners but 
not yet married accounted for 4.4% (n=4) of the sample. None of the participants were separated 
or divorced. A study that was conducted in Thailand, Brazil and Zambia also indicated that 
marriage was not a prerequisite for most women aged between 20-25 years who fell pregnant 
(Costelloe  et al. 2015). 
5.2.3 Employment status of the participants 
The findings of this study showed that the majority of the participants were unemployed, 
accounting for 81.1% (n=73) of the sample. Those who were employed accounted for the 
remaining 18.9% (n=17) of the sample. The rate of unemployment in South Africa is very high 
due to low education levels, poverty and the large number of the population, according to 
Shisana et al (2014). 
5.2.4 Levels of education of the participants 
Majority of the participants had completed high school (58.9%, n=53), while 17.8% (n=16) of 
the participants had completed secondary school, and only 20.0% (n=18) had completed tertiary 
studies. 3.3% (n=3) of the participants had only completed primary school. These findings were 
similar to the study done in Cape Town by Shisana et al (2014), which stated that 49, 7% of 




From the findings, 51.1% (n=46) of the participants were living in a rural area and the remaining 
48.9% (n= 44) lived in an urban area. The findings of this study were similar to the study 
conducted in Thailand, Brazil and Zambia which indicated that a high number of women who are 
HIV positive lived in rural areas and were less likely to disclose their status than those living in 
urban areas  (Costelloe et al. 2015).  
There was a negative correlation between the number of times that the women had been pregnant 
and stigma (r= -0.104). There was also a negative correlation between the number of times that 
the women had been pregnant and disclosure of their HIV status (r= -0.263); this study revealed 
that participants who were pregnant more than three times experienced more stigma and were 
more likely to have disclosed their HIV status. In general, the more an antenatal clinic was 
visited, the more likely the participant was to have disclosed their HIV positive status. 
Correlation between the number of the pregnancy and stigma was also negative (r= -688), as was 
the correlation between the place of delivery and stigma (r= -029); however, the relationship 
between the number of clinic visits and stigma experienced showed a positive weak correlation 
(r=0.040). The results indicated that the relationship between the demographics and stigma was 
very weak and negative, and that there was therefore no significant correlation. The correlation 
between disclosure and the place of delivery showed a positive relationship (r=0.205), although 
it was a weak relationship, and the number of antenatal visits had a negative relationship (r= -
0.048). Thus there was no significance noted in the correlation of the results. 
5.3 Levels of HIV related stigma among women living with HIV and AIDS 
The findings of this study showed that the majority of the participants (n=35, 38.9%) strongly 
disagreed and disagreed with the statement that no one in their family knew that they had HIV. 
This indicated that the majority of the participants had disclosed their HIV status to their family 
members. Similarly, a study conducted in the North West Province, South Africa, by Nyblade, 
Jain et al. 2013) found that increased knowledge about HIV and its related stigma resulted in 
people feeling less stigma and improved their willingness to disclose their status. Another study 
by Turan and Nyblade (2013) agreed that disclosure of HIV status could be beneficial in gaining 
social support and lowering the risk of HIV infection. In contrast, the study in Thailand, Brazil 
and Zambia  reported that the decision to disclose one‘s status was associated with the perceived 
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community level influences, which led women to be less likely to disclose their HIV status 
(Costelloe et al. 2015). 
The level of HIV related stigma among the women in this study was low, because of the high 
percentage of the participants who strongly disagreed with the statements/ items 2, 4, 6, 7, 8, 9, 
10, 12, 13, 15 and 17 which were asked about the levels of stigma that the participants felt. This 
study thus agreed with the results obtained in KZN (Valencia-Garcia, Rao et al. 2016) which 
stated that although there was stigmatising of women, most people had knowledge of HIV and 
stigma and were willing to give support to the people living with HIV.HIV stigma continues to 
impact this pandemic of HIV, the results of a study on Peruvian women by highlighted the 
experiences of stigma in health care providers and these findings are likely to be the same for 
women all over the world (Ahmed, 2017).  
5.4 Disclosure patterns among women living with HIV and AIDS 
The majority of the participants had disclosed their HIV status to family members, and these 
results were not in agreement with a study in Thailand (Turan and Nyblade 2013), where 60% of 
the participants indicated a lack of disclosure, especially to their male partners and to their family 
members. This lack of disclosure appeared to be a barrier to the use PMTCT. Disclosure 
improved physical well-being by facilitating people living with HIV‘s ability to obtain services 
to manage their illness (Okoror et al. 2014). 
In this study the results showed that the majority of the participants had disclosed their HIV 
status to their family, contradictory to the study conducted in Africa (Zambia) (Ojikutu, et al. 
2016) which stated that 67% of women disclosed their HIV status to their sexual partners; and a 
study conducted in Malawi (Geary et al. 2014), where almost 66% of the survey sample reported 
that they had disclosed their HIV status to their spouse or to their sexual partners only. 
Disclosure patterns were also significantly more likely among men compared to women, as they 
generally had higher levels of education, and were also more likely among those owning a radio 
as this facilitated greater access to HIV information (Geary, Parker et al. 2014). 
HIV status disclosure has proven effective in decreasing transmission to the HIV negative 
partner by raising risk awareness and heightening the need for HIV prevention, including routine 
counseling and testing, pre-exposure prophylaxis, and condom use (Kamen, Arganbright et al. 
2015). For women living with HIV, the decision to disclose may be influenced by culturally 
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determined, community-level stigma and norms, and understanding the impact of community 
HIV stigma and gender norms on disclosure among women living with HIV in different 
countries may inform intervention development Further it is noted that single women may be less 
likely to disclose their HIV status due to fear of loss of relationship and economic security. 
(Ojikutu et al. 2016).  
5.5 Correlation between demographics and stigma 
Pearson‘s correlation was performed to establish the relationships between the age of the 
participants and stigma. The results shows that there was a positive weak correlation (r=0.033) 
between age and stigma. This study indicated that there was no significant correlation; however, 
the results showed that stigma affects all ages, and all age groups were therefore included in 
those that had disclosed their HIV status. These findings agreed with those of Velloza et al. 
2015) who asserted that most women were willing to disclose their HIV status even though they 
experienced stigma in their community and family groups. Thus, the study conducted by Shisana 
et al (2016) revealed that married women experienced more stigma than unmarried women did. 
In general, if one is married one needs to be honest with one‘s partner, however men often shift 
the blame for a positive HIV status to women; therefore disclosing HIV status is not necessarily 
to the woman‘s advantage. In support of this, a study in African countries, Thailand, Brazil and 
Zambia revealed that unmarried women were less likely to disclose their status to their sexual 
partners (Costelloe,  et al. 2015).  
This study showed a level of stigma among participants irrespective of employment status, this is 
aligned to Shisana et al (2016) revealed that unemployed women experienced more stigma than 
those that were employed. The level of stigma experienced also varied between the participants 
from urban and rural areas, as those residing in rural areas experienced more stigma than those in 
the urban areas. In this study the participants in the rural areas disclosed their status more than 
those in the urban areas, and the researcher thinks that that is why the rural people experienced 
more stigma and discrimination than those in the urban areas. Research on anticipated stigma has 
demonstrated that increased fear of discrimination leads to psychological distress, decreased 
quality of life, and poor retention in care (Ojikutu, Pathak et al. 2016). Although there was no 
significant correlation between the demographic variables and stigma in this study, research on 
women revealed that women account for half of the people living with HIV worldwide and may 
experience more stigma than men, therefore there is a need to develop interventions for HIV-
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positive women, especially when many women face various forms of marginalisation including 
poverty, lack of health insurance, gender inequality and class oppression (Valencia-Garcia, Rao 
et al. 2016).  
5.5.1 Correlation between demographics and disclosure 
Pearson‘s correlation was performed to establish the relationship between the demographics and 
disclosure. The results of this study showed that there was a positive weak relationship (r=0.086) 
between age and disclosure, however African studies indicated that older women were less likely 
to disclose their HIV status than those of a younger age; thus age was associated with non-
disclosure and the researchers also stated that in pregnant and post-partum women, a younger 
age was found to be a consistent predictor of disclosure (Ojikutu, Pathak et al. 2016).  The 
findings of this study showing those aged 26-30 years were more likely to disclose their status 
than those aged 20 -25 and 31-35 years.  The results of this study also showed that there was a 
negative correlation between marital status and disclosure, and the findings from the study in 
African countries  in Thailand, Brazil and Zambia reported that 95% of unmarried women were 
less likely to disclose their status to their partners, due to fear of rejection by their partners 
(Ojikutu, Pathak et al. 2016). 
 
5.5.2 Correlation between stigma and disclosure 
Pearson‘s correlation performed to establish the relationships between stigma and disclosure, and 
the results showed a positive weak correlation (r=0.18+p= 0.1). This meant that when the level 
of stigma rose, so too did the disclosure pattern. Velloza et al (2015) agreed with these results, 
attesting that when people who were HIV positive disclosed their status, their partners and 
family stigmatised them. 
Disclosure of HIV status is considered essential for prevention, treatment and support of people 
living with HIV, however disclosing status leads to stigmatisingbehavior and the argument has 
been made that disclosure to spouses was positively associated with perceptions of better health 
for women, but not for men (Geary, Parker et al. 2014).  
5.6 Recommendations  
In line with the findings of the study, the following recommendations are made for, nursing 
practice, management education and research. 
85 
 
5.6.1 Nursing practice 
The information from this study needs to be presented to the nursing management as the 
researcher will submit the results of this study to the hospital board, to assist nursing practice to 
improve the standards of confidentiality and to correct service providers‘ attitudes towards HIV 
positive women. The study findings may also promote universal care in the health care centres 
by combining all services in one room. Understanding the perceived levels of stigma and the 
disclosure patterns of HIV among women, is an important contribution to nursing practice, as 
this information can enable nurses working with women living with HIV to better deal with HIV 
related stigma. Such initiatives can be incorporated within the health education screening 
performed at antenatal care and maternal and women health services.  
5.6.2 Nursing management 
The provision of ongoing counselling is required for people living with HIV and AIDS. Proper 
counselling should be provided with guidelines for PMTCT, and treatment should be in line with 
the specific needs of the patients. 
5.6.3 Education 
The educators and nursing staff need to be united and work together to identify problems in 
health care settings to reduce stigma. They also need to form support group and encourage 
clients to join them. They also need to do home visits, schools and community to provide health 
education on HIV and stigma. There is a need for collaboration between educators and nurses so 
that the appropriate and relevant  knowledge on is provided to staff in order for them to provide 
the proper care and health education for people living with HIV and AIDS. Such knowledge 
needs to focus on the psychosocial determinates of HIV and especially how it relates to quality 
of care and the quality of life for the person living with HIV. Nurses and midwives need to 
adequately prepare in understanding the stigma process and the expressions, actions and nuances 
that can trigger stigma and lead to received stigma by the person living with HIV. This is 
important and nurses and midwives are often the first point of care that women or persons living 
with HIV access and thus, the interaction with the nurse and the person living with HIV can 
determine how the stigma is managed and the disclosure of the persons HIV status managed,  
5.6.4 Nursing Research 
More research should be done on this research topic, to include other hospitals as this study 
focussed on one department in one hospital. A multisite quantitative study to measure HIV 
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related stigma among women living with HIV may be useful to understand the stigma processes 
as it is experienced in different contexts within the country. Further to this, a qualitative study 
will be useful to better understand how women living with HIV manage and experience stigma, 
this is useful to better understand the coping strategies that are used to manage HIV related 
stigma.  
5.7. Limitations of the study 
 This study was limited by the method of sampling and the method of data collection. The study 
used purposive sampling to select the participants for the study and a quantitative method, which 
meant that the researcher was unable to obtain more in-depth information from the participants 
as the data collection tools did not allow collection of in-depth information. In future, a 
qualitative research methodology should be employed to conduct another study to illicit more in-
depth information. Finally, as this study was conducted in only one hospital in the eThekwini 
district of KZN, the findings may not be generalization to every setting. 
5.8 Summary of the study 
This study focussed on the perceived HIV related stigma and disclosure patterns among women 
living with HIV and AIDS in a selected hospital in the eThekwini district, KZN. It explored the 
perceived stigma among women living with HIV, the inter-relationship between demographics 
and stigma, the inter-relationship between demographics and disclosure, and the inter-
relationship between stigma and disclosure. A total of 90 participants were purposively selected 
for the study and a validated questionnaire was administered to them.  
5.9 Conclusion 
HIV related stigma among women is a major barrier to disclosing HIV status, and the findings of 
this study have added to the existing knowledge of the perceived stigma and patterns of 
disclosure among women living with HIV and AIDS. This study indicated that although there are 
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Appendix 4: Consent form and information sheet 
Participants’ information sheet and informed consent 
Title of topic: An exploratory descriptive study on the perceived levels of stigma and 
disclosure patterns among women living with HIV and AIDS in a selected hospital in 
KwaZulu-Natal 
Dear participant 
My name is Lucia Mdluli; I am a student at the University of KwaZulu-Natal, pursuing a 
Master‘s degree in Advanced Midwifery, Maternal and Child Health. One of the requirements 
for the degree is to conduct a research project. 
You have been requested to take part in a research study. This form gives information on the 
study in order to help you to decide if you want to participate. Take as much time as you like to 
read over this information carefully. Please ask any questions that you may have on the study. It 
is ok if you decide not to participate, and if you decide to participate, you may stop participating 
in the study at any time, without suffering any negative consequences.  The aim of the study is to 
explore and describe the perceived levels of HIV related stigma among women living with HIV. 
This study wants to understand the levels of HIV related stigma among women within the 
community and family, and the levels of disclosure among the women.  
The information provided will be used for research purposes only and will be kept confidential 
by the researcher and supervisor. The study has no personal gain (financial reimbursement). The 
researcher will appreciate your participation.  
Procedures 
If you agree to participate in the study, the following will take place: 
You will be issued a questionnaire to answer questions about your demographic data, your 
reproductive history and your experience or opinion of how people living with HIV are being 
treated in the community, by the health care services and by the family. The questionnaire will 
take about 30 minutes to complete. 
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Risks and discomforts: Some of the questions ask about your experience living with HIV, and 
these questions do not have right or wrong answers, so feel free to answer as you see fit. You are free 
to stop completing the form at any time, should you wish to do so, and your care at the clinic will 
NOT be affected. You will be asked sensitive questions about stigma, so feel free to refuse to answer. 
Confidentiality 
Your name will not be recorded on the questionnaire nor reported in any project document and all of 
your answers will be kept strictly confidential. It will be only written on the consent form because, 
when agreeing to participate, it is a requirement that you write your name and sign the form. There 
will be no link between your consent to participate in the study and your completed questionnaire. 
This study has been ethically reviewed and approved by the UKZN Biomedical Research Ethics 
Committee. 
In the event of any problems or concerns/questions you may contact the researcher at (provide 
contact details), the research supervisor, or the UKZN Biomedical Research Ethics Committee, 
contact details as follows: 
Name of the researcher: Lucia Mdluli 
Contact details:  School of Nursing and Public Health 
 5th Floor Desmond Clarence Building 
                                                Howard College Campus,  
                                                 University of KwaZulu-Natal  
                                                 Faculty of Health Sciences,  
                                                 4041,  
                                                 DURBAN,  
                                                 RSA 




or     Bonahmd68@gmail.com 
 
Supervisor:   Dr. Joanne Naidoo 
    Email: naidoojr@ukzn.ac.za 
                                                Contact details: 0312602213 
 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office, Westville Campus  
Govan Mbeki Building  
University of KwaZulu-Natal 
Private Bag X 54001, Durban, 4000  
KwaZulu-Natal, SOUTH AFRICA  
Tel: 27 31 2602486 - Fax: 27 31 2604609  
Email: BREC@ukzn.ac.za 
 
 I have been given a copy of this consent form to keep. 
 
Consent to participate in research project 
I………………………………………………………… (Your full name) hereby confirm that I 
understand the contents of this study document and the nature of the research project, and I 
consent to participating in the research project.  
I understand that PARTICIPATION IS VOLUNTARY and I am at liberty to withdraw from the 
project at any time, should I so desire. 
……………………………………………………………….. 
Signature and Date 
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Appendix 6: Questionnaire 
Instructions for the participants 
The following questions will be divided into sections A, B and C; please answer all questions. 
The following questions relate to your socio-demographic data,  
Please place a tick in the appropriate box for the answer(s) below. 
 
Section A-1 Socio-Demographic Data 
 
1.      What is your age in years? 
 







Living with partner but not  
Married 
   
4.  What is your ethnicity/race? 
 African     Indian   
 
 White                                      Coloured 
 Other (specify) ………………….............. 
 
5. What is your religion? 
Roman Catholic               Christian       Zion  
 




6.  Are you currently employed?           Yes                           No           
     If yes what is your occupation? 
           Specify………………………………………….. 
    5.1. If not employed who is the breadwinner at home?....................................... 
 
6. What is your highest level of education? 
Completed primary school   
 
Completed secondary school    
  




7. Where do you live? 
Rural area                                                                          Urban area 
 
8.With whom do you live? 








Section A-2: Reproductive History 
9. How many times have you been pregnant? 
      First pregnancy    Second pregnancy 
          Third pregnancy          More than third pregnancy 
 
 
10. How many children do you have? 
None                                       One child  
Two children                           Three children 
 Four children     More than four children 
 
State the number of children if more than four......................................... 
 
11. If you were pregnant before, where was your last baby delivered? 
 Home     
 Hospital   
 
 Health Centre        
 
 Private Clinic   
 
 No previous pregnancy 
 
12. In the current pregnancy, how many times have you visited the Antenatal clinic?  






State the number of visits to the antenatal clinic if more than four 
 
Section B 
The following questions ask about your experience, opinion and how people with HIV are 
treated. 




Disagree  Agree Strongly 
agree 
1.No one in my family knows that I have 
HIV  
SD D A SA 
2.I feel guilty because I have HIV SD D A SA 
3.People‘s attitudes about HIV make me 
feel worse about myself 
SD D A SA 
4.Telling someone that I have HIV is 
risky 
SD D A SA 
5.People with HIV lose their jobs when 
their employers find out 
SD D A SA 
6.I work hard to keep my HIV status a 
secret 
SD D A SA 
7.I feel I am not as good as others 
because I have HIV 
SD D A SA 
8.I never feel ashamed of HIV SD D A SA 
9.People with HIV are treated like 
outcasts 
SD D A SA 
10.Having HIV makes me feel dirty SD D A SA 
11.Most people believe that a person who 
has HIV is dirty 
SD D A SA 
106 
 
12.I prefer to avoid having friends 
because I have HIV 
SD D A SA 
13.Since learning I have HIV, I feel set 
apart and isolated from the rest of the 
world 
SD D A SA 
14.Most people think that a person with 
HIV is being punished by God 
SD D A SA 
15.Having HIV makes me feel that I‘m a 
bad person 
SD D A SA 
16.Most people with HIV are rejected 
when others find out 
SD D A SA 
17.I am very careful who I tell that I have 
HIV 
SD D A SA 
18.Some people who know that I have 
HIV distance themselves from me 
SD D A SA 
19.Since learning I have HIV, I worry 
about being discriminated against 
SD D A SA 
 
Section C 
The following questions ask about your HIV status, please tick the correct answer. 
1. Did you disclose your HIV status to anyone? 
 Yes     No  
 
2. If you can share the results with someone, whom would you tell? 
    Family member  
 
    Spouse or partner   
 






3. What was the reaction of that person you told about your HIV status? 
     Rejected                                          Gave support 
 
Other (specify)...................................... 
4. If not telling anyone about your HIV status, what is your reason for not telling anyone? 
Stigma and discrimination    
 Fear of people not maintaining my confidentiality 
 
 Knowing HIV-status has no advantage. 
 
 Other reason specify ………………………………………………. 
5. In the family or community, how often did the following events happen because of your HIV 
status? 0=Never,  
 1=once or twice, 
 2=several times  
 3=most of the time 
 
(a) Someone scolded me......... 
(b) Someone insulted me.......... 
(c) I was blamed for my HIV status................... 
(d) I was told that I have no future...................... 
(e) I was told that God is punishing me................ 
(f) I was called bad names.................................... 
(g) Someone mocked me when I passed by........... 







Appendix 6: IsiZulu Version 
Ifomu lemininingwane nemvume yobambe iqhaza 
Isihloko: Ukuhlolwa nokuchazwa kwamazinga ezinkolelongezici kubantu besifazane 
abaphila nengculazi kwezaba khulelwe nezempilo yabantwana ezibhedlela ezikhethekile 
zesiFunda saseThekwini. 
Mbambiqhaza 
Igama lami ngu-Lucia Mdluli; ngingumfundi eNyuvesiYaKwaZulu-Natali, ofundela iziquze-
Master in Advanced Midwifery, Maternal and child health. Enye yezidingo yaleziziqu ukuba 
kwenziwe ucwaningo. 
Uyacelwa ukuba ubambe iqhaza kulolucwaningo. Lelifomu linemininingwane ngocwaningo 
ukuze ukwazi ukuzinqumela ngokubamba iqhaza. Thatha isikhathi osidingayo ukuthi ufunde 
lemininingwane ngokucophelela. Ngicela ubuze noma imiphi imibuzo ongaba nayo 
ngocwaningo. Akunankinga futhi uma ukhetha ukungalibambi iqhaza. Uma ukhetha ukubamba 
iqhaza, ungahoxa noma inini uma ungasathandi ukuqhubeka. Inhloso yocwaningo ukuhlola 
nokuchaza kwamazinga ezinkolelongeziciku bantu besifazane abaphila nengculazi. Lolu 
cwaningo luhlose ukuqonda ngamazinga ezici kwabesifazane abaphila nengculazi emphakathini 
nasemindenini kanye namazinga okudalula ukubanengculazi phakathi kwabesifazane. 
Ulwazi olutholakele luzosetshenziselwa ucwaningo kuphela futhi luzogcinwa luyimfihlo 
ngumcwaningi nomeluleki wakhe. Ucwaningo alunanzuzo yezimali kumuntu. Umcwaningi 
uzokuthokozela ukuzibandakanya kwakho. 
Izinqubo 
Uma uvuma ukubamba iqhaza kulolucwaningo, kuzokwenzeka lokhu okulandelayo:  
Uzonikezwa uhlumibuzo lapho uzophendula imibuzo mayelana nawe, umlando wakho 
kwezocansi noma imibono yakho mayelana nendlela okumele kuphathwe ngayo abantu abaphila 
nengculazi emphakathini, emitholampilo nase mndenini. Lokhu kuzothatha imizuzu engama-30. 
Ubucayi Nokunga phatheki kahle: Eminye yemibuzo ozoyibuzwa ngomlando wakho 
ngokuphila nengculazi.  Le mibuzo ayinazimpendula ezilungile noma ezingalungile,  ngakho 
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ungayeka ukugcwalisa ifomu noma yinini.  Uzobuzwa imibuzo ebucayi mayelana nezici 
ngengculazi ngakho khululeka wenqabe ukuphendula. 
Ubumfihlo 
Igama lakho ngeke libhalwe ohlwini mibuzo noma lisetshenziswe kweminye imibhalo futhi zonke 
izimpendulo zakho zizohlala ziyimfihlo. Lizo bhalwa kuleli fomu kuphela ngoba kungumgomo 
ukuba libhalwe futhi usayine. Ngeke kube khona ukuxhumana Phakathi kwemvume yakho 
yokubamba iqhaza kulolu cwaningo nohlumibuzo. 
Lolu cwaningo selubuyekeziwe ngokwe zenkambiso futhi lugunyazwe yikomidi lezenkambiso 
kwezocwaningo ngezempilo kwelapha lase-UKZN (inombolo yokugunyazwa ___________). 
Uma kuba khona izinkinga noma ukungathokozi/imibuzo ungathintana nomcwaningi  (faka 
imininingwane yomncwaningi), umeluleki wocwaningo noma Ikomidi lase UKZN lezocwaningo 
ngezempilo kwela lapha kokulandelayo:  
Igama Lomcwaningi:  Lucia Mdluli 
Imininingwane Yokuxhumana:  School of Nursing and Public Health 
5th Floor Desmond Clarence Building 
Howard College Campus,  
University of KwaZulu-Natal  




Cell phone: 0835903095 




Umeluleki: Dr. Joanne Naidoo 
 Email: naidoojr@ukzn.ac.za 
Contact details: 0312602213 
Imvume yokubamba iqhaza 
Nginikeziwe ikhophi yalelifomu ukuba ngiyigcine. 
Imvume yokubamba iqhaza kulolucwaningo  
Mina………………………… (Igama lakho eligcwele) ngiya qinisekisa lapha ukuthi 
ngiyakuqonda okumayelana nalombhalo ngalolucwaningo nohlobo locwaningo futhi ngiyavuma 
ukubamba iqhaza kulo.  
Ngiyaqonda ukuthi UKUBAMBA IQHAZA AKUPHOQELEKILE futhi nginelungelo lokuhoxa 
nomayinini, umangifisa.……………………………………………………………….. 
Ukusayina                                                                Nosuku 
.......................................                                           .......................................... 
 
Uhlumibuzo 
Imiyalelo yababambe iqhaza 
 
Le mibuzo izoba nezigaba  A, B no C sicela uphendule yonke imibuzo.  
Uzobuzwa imibuzo efana nalena mayelana nolwazi ngenhlalobuwena, 




Isigaba A –1 Ulwazi Ngenhlalobuwena 
 




       Awushadile  
          Ushadile 
 
                    Uhlukanisile 
 
 
3. Ungowaliphi uhlanga/ubuzwe? 
UmAfrika   Umndiya   
Umlungu 
 
                        Omunye (cacisa) …………………. 
4. Iyiphi inkolo yakho? 





  Umnazaretha                        okunye……………........ 
 
5. Uyasebenza?   Yes                         No  
    5.1.   Uma uthi yebo, usebenza msebenzi muni? 
Chaza.............................................................. 
 
6. Izinga lakho lemfundo lingakanani ? 
Uphothul eamabanga aphansi   
 








                    Emadolobheni 
8. Uhlalanobani? 
Umndeni 
      Umngani 
 
      Cacisa……………………………………………………… 
 
Isigaba A-2: Umlando Ngezocansi 
 
9. Usukhulelwe kangaki? 
Okokuqala   Okwesibili 
Okwesithathu  Okungaphezulu kokuthathu 










      Yisho isibalo sezingane onazo 
11. Uma wake wakhulelwa, wazalelwaphi umntwana wakho wokugcina? 
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Ekhaya    
 
            Esibhedlela   
 
            Emtholampilo     
 
            Angikazengikhulelwe 
 
 
12. Kulokhu kukhulelwa kwamanje, usuvakashele kangaki eklinikhi yabakhulelwe?  
      Kanye   
Kabili  
Kathathu 
      Kane nangaphe 
 
IsigabaB 
Lemibuzo elandelayo ibuza mayelana nosuke wabhekana nakho, imibono yakho nokuthi kumele 
baphathwe  kanjani abantu abanengculazi. 
Esitatimendeni ngasinye kokelezela impendulo yakho:Uphika kakhulu , Uyaphika,  Uyavuma 
kakhulu , Uyavuma, 
Izitatimende Uphika kakhulu Uyaphika Uyavuma Uvuma 
kakhulu 
Akekho owaziyo ukuthi 
nginengculazi emndenini 
SD D A SA 
Ngizizwa nginecala ngoba 
nginengculazi 
SD D A SA 
Indlela abantu ababuka ngayo 
ingculazi ingenza ngizisole 
kakhulu 
SD D A SA 
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Ukutshela umuntu ukuthi 
nginengculazi kunobungcuphe 
SD D A SA 
Abantu abanengculazi baphelelwa 
umsebenzi uma abaqashi bethola 
ukuthi abasebenzi banengculazi 
SD D A SA 
Ngisebenza kanzima ukugcina 
isimo sami sengculazi siyimfihlo 
SD D A SA 
Ngiyazenyeza ngoba 
nginengculazi 
SD D A SA 
Anginamahloni ngengculazi SD D A SA 
Abantu abanengculazi baphathwa 
njengabantu banga phandle 
SD D A SA 
Ukuba nengculazi kungenza 
ngizizwe ngingcolile 
SD D A SA 
Abantu abaningi bakholelwa 
ukuthi umuntu onengculazi  
ungcolile 
SD D A SA 
Ngincamela ukungabi nabangani 
ngoba nginengculazi 
SD D A SA 
Kusukela ngithola ukuthi 
nginengculazi,  ngizizwa 
ngikhishwa inyumbazane, 
ngihlukene nomhlaba wonke 
SD D A SA 
Abantu abaningi bacabanga 
ukuthi abantu abanengculazi 
basuke bejeziswa uNkulunkulu 
SD D A SA 
Ukuba nengculazi kungenza 
ngizibone njengomuntu 
ongalungile 
SD D A SA 
Abantu abaningi abanengculazi 
bayalahlwa uma abanye bethola 




Ngiyaqaphela ukuthi ngitshela 
bani ngesimo sami sokuba 
nengculazi 
SD D A SA 
Abanye abantu abazi ukuthi 
nginengculazi bayaziqhelelanisa 
nami 
SD D A SA 
Emuva kokwazi ukuthi 
nginengculazi,  ngisaba 
ukuthingizo cwaswa 
SD D A SA 
 
Isigaba C 
Imibuzo elandelayo ikubuza ngesimo sakho sengculazi, sicela ukhethe impendulo efanele 
(1) Ukhona osumtshelile ngesimo sakho sengculazi?  
Yebo    Cha 
 
(2)  Uma ungatshela umuntu ngesimo sakho sengculazi, ungatshela bani?  
Ilungu lomndeni 
 
Ozwana naye noma obambisene naye 
      Umngani 
 
Omunye  (cacisa).................................................. 




(2) Uma ungatshelanga muntu ngesimo sakho sengculazi, kwakuyisiphi isizathu salokho? 
  
ukuthi bayacwasana   
 
Ukwesaba ukuthi abantu ngeke bagcine lokhu kuyimfihlo 
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Ukwazi ngesimo sakho sengculazi akusizi ngalutho. 
 
Ezinye izizathu. chaza ………………………………………………. 
6. Emndenini noma emphakathini sekwenzeke kangaki lokhu okulandelayo  ngenxa 
yesimo sakho sengculazi?  
0-akukaze kwenzeke,  
 1-kanye nomakabili, 
                       2-kaningana 
                       3-kwenzeka izikhathi eziningi 
 
(i) Kukhona owangithethisa......... 
(j) Kukhona owangithuka.......... 
(k) Kwasolwa mina ngesimo sami sengculazi................... 
(l) Ngatshelwa ukuthi anginakusasa...................... 
(m) Ngatshelwa ukuthi uNkulunkulu uyangijezisa................ 
(n) Ngabizwa ngamagama angemahle.................................... 
(o) Kukhona owangidelela ngidlula eduze kwakhe........... 
(p) Abantu babecula amaculo athukayo umangidlula.............. 
 
 











Appendix 7: Letter from Language Practitioner 
Dear Client 
This is to confirm that I Njabulo Marvin Manyoni is a full-time Language Practitioner in the 
employ of the University of KwaZulu-Natal within the Language Planning and Development 
Office.  
 I am a qualified Language Practitioner with 16 years of experience as a 
translator/interpreter/proofreader and editor. Our field does not have a legislated professional 
body as yet and as such, accreditation is not possible. My current role in the University is to 





 Terminology Development 
 Transcription 
I also provide these services to the general public at a negotiated fee. 
I trust the above is in order. 
 
Kind regards 
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based training course “Protecting Human Research 
Participants”. 
Date of completion: 01/11/2016  
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